INSERT INTO `elements_sites` VALUES (12174,12174,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:44','2024-05-24 14:57:44','5c9355bc-3459-4c1e-889c-b8038213c150'),(12175,12175,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:44','2024-05-24 14:57:44','97f74d0e-70b2-4001-9d17-6b7733c12a02'),(12176,12176,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:44','2024-05-24 14:57:44','4f411f72-0915-43ca-9c85-7988ab39139e'),(12177,12177,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:47','2024-05-24 14:57:47','4194017f-be36-48db-b7e6-9b1900f1da4d'),(12178,12178,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:47','2024-05-24 14:57:47','d752247f-82d8-4a4d-8ad2-0498466e5989'),(12179,12179,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:47','2024-05-24 14:57:47','f8be233f-adf7-4215-b9d5-e21a8be1feb7'),(12180,12180,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:47','2024-05-24 14:57:47','a187e8ff-4e39-44c3-99a3-1bc8d79de370'),(12181,12181,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:47','2024-05-24 14:57:47','1ec850a5-7b49-4302-be16-28e45619a211'),(12182,12182,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:57:47','2024-05-24 14:57:47','51d8c2de-8780-4310-b40b-6f5749f59a58'),(12183,12183,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:47','2024-05-24 14:57:47','b49b7e34-0bbb-4015-8e9b-49b2f40728ec'),(12184,12184,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:57:47','2024-05-24 14:57:47','b2cfc55c-aa06-4ae1-97a8-cee55d68334b'),(12185,12185,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:47','2024-05-24 14:57:47','cee1d40e-e4d7-44e1-b5f8-38b05180a3fa'),(12186,12186,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\"}',1,'2024-05-24 14:57:47','2024-05-24 14:57:47','3616b4e1-4be1-4761-9c15-51e45a559589'),(12187,12187,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:50','2024-05-24 14:57:50','0ef2efc8-6473-4de4-8682-74e2f6c0b8a2'),(12188,12188,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:50','2024-05-24 14:57:50','585720dd-e4c4-47c4-988f-55736bde0aac'),(12189,12189,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:50','2024-05-24 14:57:50','c73b6547-8c0a-4dc4-9e44-e11f0498ab70'),(12190,12190,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:50','2024-05-24 14:57:50','aad6f433-1be3-4ae0-abee-a228067144d7'),(12191,12191,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:51','2024-05-24 14:57:51','1bb8d5dd-44f1-4d7b-b33d-35cc8b911fa6'),(12192,12192,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:57:51','2024-05-24 14:57:51','56561270-22ab-4b72-afe8-9604950cad9b'),(12193,12193,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:51','2024-05-24 14:57:51','125f1192-7615-4863-883a-0b43024a829c'),(12194,12194,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:57:51','2024-05-24 14:57:51','7cc5c324-090f-4d57-9415-9ad744beb47c'),(12195,12195,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:51','2024-05-24 14:57:51','5c5a1ba1-1598-4663-8739-e29a918b5dd7'),(12196,12196,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\"}',1,'2024-05-24 14:57:51','2024-05-24 14:57:51','1653fad2-8b0f-4e59-8414-f7a4b875e348'),(12197,12197,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:53','2024-05-24 14:57:53','2304baca-b4bc-4bf3-ace8-5844a5bf1a56'),(12198,12198,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:57:53','2024-05-24 14:57:53','3c47ae03-8f72-424b-bcdf-124a368677b2'),(12199,12199,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:53','2024-05-24 14:57:53','834b22be-010d-4032-b3fb-bb84cff7feb0'),(12200,12200,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:57:53','2024-05-24 14:57:53','e54773f0-bb04-4b08-b802-41347c5b94ee'),(12201,12201,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:53','2024-05-24 14:57:53','060235cf-2a09-41cd-9829-1d77bb9038ed'),(12202,12202,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\"}',1,'2024-05-24 14:57:53','2024-05-24 14:57:53','e5a35520-045e-41cb-b3db-0dcb2aed741e'),(12203,12203,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:55','2024-05-24 14:57:55','f88d1082-eea7-46d0-8c3b-74d823492fb1'),(12204,12204,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:57:55','2024-05-24 14:57:55','d07c8d25-a5c8-4379-9a2a-8fd20bcf5dea'),(12205,12205,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:55','2024-05-24 14:57:55','416d633d-eace-4e2f-8742-563ed5de59d7'),(12206,12206,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:57:55','2024-05-24 14:57:55','8c7b7f58-b6e9-4b1f-a059-b0abd02dbb4c'),(12207,12207,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:56','2024-05-24 14:57:56','c76f039c-bb59-4e92-9876-751999b40c2c'),(12208,12208,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:57:56','2024-05-24 14:57:56','26c90865-7cf2-4676-a26d-ebdf85edf350'),(12209,12209,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:56','2024-05-24 14:57:56','825e392a-ec71-4c08-aee4-d9d6d2dcc816'),(12210,12210,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:57:56','2024-05-24 14:57:56','1c7c537b-d0b1-4af2-8d87-a09023f6ad5d'),(12211,12211,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:56','2024-05-24 14:57:56','253c2319-4cfd-4f02-a979-efaf12f2cd4d'),(12212,12212,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\"}',1,'2024-05-24 14:57:56','2024-05-24 14:57:56','72bca78e-ebe6-4a65-a7b7-ccf5223623a9'),(12213,12213,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:58','2024-05-24 14:57:58','be97bacf-3ca9-4926-9307-a8424a956393'),(12214,12214,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:57:58','2024-05-24 14:57:58','634d2b7f-3713-4ffb-b8f7-f331a3c5a9db'),(12215,12215,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:58','2024-05-24 14:57:58','b07d0e2b-b104-4b27-b756-9deb6261f7d0'),(12216,12216,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:57:58','2024-05-24 14:57:58','0f0d2a6f-5999-4467-b238-403f675219e9'),(12217,12217,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:57:58','2024-05-24 14:57:58','6242b235-525c-42ad-9e4e-9bfa5a51738c'),(12218,12218,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:57:58','2024-05-24 14:57:58','cd450483-868a-4403-83a4-7e4267ff9a6a'),(12219,12219,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:00','2024-05-24 14:58:00','6045ffcc-3c57-4701-8ef9-d0f433b14d36'),(12220,12220,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:00','2024-05-24 14:58:00','b0752a92-6dec-4791-9f88-1ffd19363d1e'),(12221,12221,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:01','2024-05-24 14:58:01','625af159-9e1c-4da0-8788-887672e403ab'),(12222,12222,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:01','2024-05-24 14:58:01','132ebed6-b366-4fe8-aeda-72b67b80c942'),(12223,12223,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:01','2024-05-24 14:58:01','12017314-3620-4ba2-bdba-06229b4d1f1b'),(12224,12224,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:58:01','2024-05-24 14:58:01','a815ca52-376f-4615-9d5c-b96f467c60a9'),(12225,12225,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:01','2024-05-24 14:58:01','ad737c6e-4cda-4d70-903c-be54935fc241'),(12226,12226,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:58:01','2024-05-24 14:58:01','6473a084-74e8-4a36-a6ba-20e6f246824b'),(12227,12227,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:01','2024-05-24 14:58:01','76f8f152-926c-4ed8-a70a-7be9b85e9d79'),(12228,12228,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:58:01','2024-05-24 14:58:01','c48b0540-f7b1-4136-9e1b-4ad5afe02329'),(12229,12229,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:04','2024-05-24 14:58:04','c3bf0f11-6688-4626-bab3-a8201889d84f'),(12230,12230,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:04','2024-05-24 14:58:04','4592d4c7-f6e1-4444-a644-dd2497ef7b4a'),(12231,12231,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:04','2024-05-24 14:58:04','2054455e-722d-49d1-be41-a45692cd6c41'),(12232,12232,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:04','2024-05-24 14:58:04','04c5bb3a-ceee-47e8-9f9f-bd990b7173e7'),(12233,12233,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:06','2024-05-24 14:58:06','0c6f49ee-48c3-447a-9640-e0221948d5b3'),(12234,12234,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:58:07','2024-05-24 14:58:07','d723a8a5-50d2-47f7-aa43-6400b2fc6e1c'),(12235,12235,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:07','2024-05-24 14:58:07','b815aa1a-bc2c-4eab-92d5-7a0edc595174'),(12236,12236,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:58:07','2024-05-24 14:58:07','a7798db4-483f-4443-a4d2-ed98288fcb70'),(12237,12237,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:07','2024-05-24 14:58:07','aa1696de-276c-4214-a58c-4a413d054036'),(12238,12238,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:58:07','2024-05-24 14:58:07','89c50677-2c2e-446d-b49e-aabb6907d0bc'),(12239,12239,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:07','2024-05-24 14:58:07','67e8a31f-357e-440c-b062-fce5dade4dc2'),(12240,12240,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:58:07','2024-05-24 14:58:07','ab4545da-1d24-49c5-ba58-d6d76a14b253'),(12241,12241,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:09','2024-05-24 14:58:09','37cf6fd6-d2a1-45e2-a1bd-dd846ba2e54f'),(12242,12242,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:09','2024-05-24 14:58:09','c9e74251-a7af-430d-b272-e1caf68bd781'),(12243,12243,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:09','2024-05-24 14:58:09','c9d7837a-92b5-410b-913d-33b3ff736dad'),(12244,12244,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:09','2024-05-24 14:58:09','5e6b7704-b401-4180-b635-5fa694fd45d7'),(12245,12245,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:10','2024-05-24 14:58:10','fffe5e8a-5669-45d1-a14e-eee2d2248ed3'),(12246,12246,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:58:10','2024-05-24 14:58:10','c6e31ada-903a-44b3-9ce4-efcab03c81d7'),(12247,12247,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:10','2024-05-24 14:58:10','cde0826f-5130-4561-992b-b58fbc91022c'),(12248,12248,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:58:10','2024-05-24 14:58:10','39bef893-0213-4b31-b6a0-2950f2644256'),(12249,12249,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:10','2024-05-24 14:58:10','c960a496-87c6-4a34-be64-259f514d8e8b'),(12250,12250,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:58:10','2024-05-24 14:58:10','4f526840-3d59-4a7e-9642-f5b994dafa39'),(12251,12251,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:10','2024-05-24 14:58:10','55ccd873-44d9-45c1-90ba-146d029201b7'),(12252,12252,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:58:10','2024-05-24 14:58:10','b34227e5-14d4-44fa-b8c1-0c6b0ecf5c35'),(12253,12253,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:12','2024-05-24 14:58:12','778e4854-be28-49e9-a4af-02048e35bfd7'),(12254,12254,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:12','2024-05-24 14:58:12','875e9a68-d004-4d63-aeaa-5a6bea16c97a'),(12255,12255,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:12','2024-05-24 14:58:12','032eb98b-45f3-42a1-bb3c-c4d5c044d02c'),(12256,12256,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:12','2024-05-24 14:58:12','9e81d63e-9ae3-496f-a343-aa3070616606'),(12257,12257,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:13','2024-05-24 14:58:13','d58018f7-6aae-4208-938f-aaa3df18d5fd'),(12258,12258,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:13','2024-05-24 14:58:13','463842ec-51f1-4993-b5ee-f6a86b4ea3d1'),(12259,12259,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:13','2024-05-24 14:58:13','55d04ed1-3b40-4057-9eaa-546705cc9a8d'),(12260,12260,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:13','2024-05-24 14:58:13','91b9715e-967e-4624-83bf-08efc382ec19'),(12261,12261,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:14','2024-05-24 14:58:14','466c1f3b-de0b-404d-9e01-493498e76c84'),(12262,12262,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:14','2024-05-24 14:58:14','5ad4835a-3d10-4e14-8b5d-95f977dc531b'),(12263,12263,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:14','2024-05-24 14:58:14','7298f037-d01a-4021-8126-43fbdfb844e4'),(12264,12264,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:14','2024-05-24 14:58:14','93fa2a1b-9075-4962-b59f-58fa62cd0a7d'),(12265,12265,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:15','2024-05-24 14:58:15','b635b3fd-c903-450a-a0cd-e9105aa2361e'),(12266,12266,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:16','2024-05-24 14:58:16','41c146a7-651d-4654-80da-a3983fbf9c98'),(12267,12267,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:16','2024-05-24 14:58:16','13e88842-414f-46a7-a725-ba91898e2ef5'),(12268,12268,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:16','2024-05-24 14:58:16','4649a894-6f3a-4e05-90e2-6ec3edd0d1ec'),(12269,12269,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:17','2024-05-24 14:58:17','74ce057e-d626-493c-bf7f-978d6575b17a'),(12270,12270,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:17','2024-05-24 14:58:17','b1dda64d-9fb1-426c-ac4e-afd75dade991'),(12271,12271,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:17','2024-05-24 14:58:17','4afbc90a-6a3b-4b86-8652-8c00033ecd7d'),(12272,12272,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:17','2024-05-24 14:58:17','50e12305-cbab-4319-9351-34cce21cfc20'),(12273,12273,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:18','2024-05-24 14:58:18','d48c67e3-4d62-4045-98b6-4f828bcbb8f5'),(12274,12274,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:18','2024-05-24 14:58:18','80e7e51b-66ca-4a80-8740-717f4be6ead3'),(12275,12275,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:18','2024-05-24 14:58:18','9c286910-6b2d-48f2-b462-b33d023d5f8c'),(12276,12276,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:18','2024-05-24 14:58:18','d0a3261a-749f-44e4-bcf7-41fdcc377a5d'),(12277,12277,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:19','2024-05-24 14:58:19','b46f39c0-1d04-4f61-b8e1-5632cb22390d'),(12278,12278,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:19','2024-05-24 14:58:19','9d0efae1-a96b-40aa-8cb2-fd552cade7a0'),(12279,12279,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:19','2024-05-24 14:58:19','542e04fb-2dfe-4741-84be-e2618cb3a9f7'),(12280,12280,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:19','2024-05-24 14:58:19','ec3a7cca-0b83-4035-bfb9-ad2027e0c5d8'),(12281,12281,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:20','2024-05-24 14:58:20','426570c2-bcc1-43fb-bff9-2e3732374447'),(12282,12282,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:20','2024-05-24 14:58:20','08461e14-4a60-45e7-b7c1-60bd596908aa'),(12283,12283,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:21','2024-05-24 14:58:21','3ae7539a-c14f-4280-b46d-d0747a92e0d2'),(12284,12284,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:21','2024-05-24 14:58:21','94395094-13df-474b-96ce-5f8f8831ebfa'),(12285,12285,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:22','2024-05-24 14:58:22','307555f2-752b-4a39-bccf-7a43cdf4787b'),(12286,12286,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:22','2024-05-24 14:58:22','5fe2d38b-0967-4118-9071-c003e9124b0b'),(12287,12287,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:22','2024-05-24 14:58:22','ff975e7c-93b0-4e58-8abe-1e448f370289'),(12288,12288,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:22','2024-05-24 14:58:22','72e04df5-1aa4-432a-8876-be706a295119'),(12289,12289,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:23','2024-05-24 14:58:23','74195466-7dfa-4182-b93a-6955f66cfbcc'),(12290,12290,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:23','2024-05-24 14:58:23','7b5c2e4a-1a24-4950-ac81-5e17630c9f7f'),(12291,12291,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:23','2024-05-24 14:58:23','2817d73f-cccd-4c9c-ae20-e193f43def85'),(12292,12292,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:23','2024-05-24 14:58:23','9a59fe9f-b6ae-46b0-ad1c-e49c9503cf15'),(12293,12293,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:24','2024-05-24 14:58:24','622d4c7a-dc86-4d29-a0c3-aee65fae12bc'),(12294,12294,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:24','2024-05-24 14:58:24','9186f5d4-373c-4fde-aa07-9871495d1334'),(12295,12295,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:24','2024-05-24 14:58:24','bbcd678f-e7ef-4b3c-b727-1a27732eea1b'),(12296,12296,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:24','2024-05-24 14:58:24','e9ef7077-ce98-458d-aa47-628f676b817c'),(12297,12297,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:27','2024-05-24 14:58:27','5dabcbc6-33b9-489f-b56e-6c2366c2fa0d'),(12298,12298,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:27','2024-05-24 14:58:27','6bc2a7e9-4ffa-4f36-8ae5-e58dbec89a5d'),(12299,12299,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:27','2024-05-24 14:58:27','e52a3d41-a7a1-4041-9b46-8034262a138f'),(12300,12300,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:27','2024-05-24 14:58:27','20114f88-10d2-45d8-98de-6c3a1b4ddd58'),(12301,12301,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:30','2024-05-24 14:58:30','5cd3cd65-9825-4733-abcf-31705a024024'),(12302,12302,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:30','2024-05-24 14:58:30','b0e758b6-fa03-405f-be1f-dc2f6fdf8111'),(12303,12303,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:31','2024-05-24 14:58:31','eb972841-8f60-4742-b924-3dae8792482a'),(12304,12304,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:31','2024-05-24 14:58:31','da146151-5977-444e-ae00-9059b5ee38dc'),(12305,12305,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:31','2024-05-24 14:58:31','97c4d056-72a7-4078-a7ab-b563aae096df'),(12306,12306,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:58:31','2024-05-24 14:58:31','5eef5ab6-8d5a-4484-a631-12e983a68a4e'),(12307,12307,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:31','2024-05-24 14:58:31','2b3ec511-240e-4f15-803a-23324fdad7d9'),(12308,12308,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:58:31','2024-05-24 14:58:31','9cb8a7cb-c213-4bce-ba7e-767d939786d0'),(12309,12309,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:31','2024-05-24 14:58:31','03d164d1-2967-4ef1-84af-85b99704eb7f'),(12310,12310,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:58:31','2024-05-24 14:58:31','d5c7d43f-a30e-4af9-b1ea-352a84a7f807'),(12311,12311,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:31','2024-05-24 14:58:31','1cddb4e7-fa3e-4bf7-9a91-e49a07b54c27'),(12312,12312,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Targeted Environmental Investigation Checklist for Outbreaks of Invasive Infections Caused by Environmental Fungi\"}',1,'2024-05-24 14:58:31','2024-05-24 14:58:31','fce81cd1-bdb8-40cc-a9e6-3bba5122f62f'),(12313,12313,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:34','2024-05-24 14:58:34','cd2e8fec-1ea0-4f05-9680-e7fd38e336cd'),(12314,12314,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:34','2024-05-24 14:58:34','7c6737d2-c04b-4d8a-979b-35328bf8b4f8'),(12315,12315,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:34','2024-05-24 14:58:34','51e7e566-62b2-4a05-9e8e-a088074adca8'),(12316,12316,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:34','2024-05-24 14:58:34','77692da6-21b3-4347-b4b5-0ae0cd78b19d'),(12317,12317,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:35','2024-05-24 14:58:35','c0188540-79e1-441a-a7d3-8ee554ee1564'),(12318,12318,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:35','2024-05-24 14:58:35','b5d13b83-c035-4f89-8bc4-70e37a3371ab'),(12319,12319,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:35','2024-05-24 14:58:35','cfa914cc-8a88-4468-8ee6-791406226255'),(12320,12320,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:35','2024-05-24 14:58:35','d9685120-2374-4cac-9cc6-238e2f61c1c7'),(12321,12321,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:36','2024-05-24 14:58:36','4c6fcd62-861b-416e-934f-584a4b184efe'),(12322,12322,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:58:36','2024-05-24 14:58:36','f6c6d142-22c9-4bea-9f5e-d1c1856c4380'),(12323,12323,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:36','2024-05-24 14:58:36','18feed4c-ff17-44c7-ab96-c0547a70eb39'),(12324,12324,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:58:36','2024-05-24 14:58:36','22e5b461-4019-4402-9a30-5a6c8754e7b4'),(12325,12325,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:36','2024-05-24 14:58:36','b99b4ba6-6891-4ad0-9f83-1b5675f6b48d'),(12326,12326,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:58:36','2024-05-24 14:58:36','44eb00f3-af6d-41ff-8691-23de07395961'),(12327,12327,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:36','2024-05-24 14:58:36','49025503-293f-43f0-aa4c-e5972b7b6eef'),(12328,12328,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Targeted Environmental Investigation Checklist for Outbreaks of Invasive Infections Caused by Environmental Fungi\"}',1,'2024-05-24 14:58:36','2024-05-24 14:58:36','e4df7af0-3f4b-4943-821c-ce4676e9447c'),(12329,12329,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:37','2024-05-24 14:58:37','39d3bacd-d447-4816-a078-76085ff6f391'),(12330,12330,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:37','2024-05-24 14:58:37','48db2077-db51-4427-8701-aa9e2ac3c30f'),(12331,12331,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:37','2024-05-24 14:58:37','c9707f26-4435-4a07-b918-2858bb849c43'),(12332,12332,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:37','2024-05-24 14:58:37','7ceb8b1f-feea-47a3-8f11-7ad840ff0d77'),(12333,12333,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:38','2024-05-24 14:58:38','dc1d7b48-d77a-44a0-b08c-8959deb888bc'),(12334,12334,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:58:38','2024-05-24 14:58:38','8308472e-0ab5-4749-a874-a98a96ae07e4'),(12335,12335,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:38','2024-05-24 14:58:38','e22d47d2-69f7-489e-a9a3-49275c7b3281'),(12336,12336,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:58:38','2024-05-24 14:58:38','46885dd2-c8d9-4e2b-b63e-161a28f03c99'),(12337,12337,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:38','2024-05-24 14:58:38','69b9fb3e-2eb4-4524-9281-7feb68f76507'),(12338,12338,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:58:38','2024-05-24 14:58:38','078c6d7d-9d43-42bd-8eef-6cf4a6122a35'),(12339,12339,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:38','2024-05-24 14:58:38','61e0fee0-f368-4a59-9f53-40adbad46ae6'),(12340,12340,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Targeted Environmental Investigation Checklist for Outbreaks of Invasive Infections Caused by Environmental Fungi\"}',1,'2024-05-24 14:58:38','2024-05-24 14:58:38','d9bade90-481e-4e63-b727-8a47d384a8f7'),(12341,12341,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:39','2024-05-24 14:58:39','f98b316e-274b-4acf-9bcb-4ede50f2182c'),(12342,12342,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:58:39','2024-05-24 14:58:39','7b634375-d5ff-4fa4-8be9-bbdc558d529a'),(12343,12343,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:39','2024-05-24 14:58:39','927ff284-0813-4c9b-8b33-f5155044adf2'),(12344,12344,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:58:39','2024-05-24 14:58:39','226a9c65-5f57-4dd5-9e86-d48f8e888a25'),(12345,12345,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:39','2024-05-24 14:58:39','26245f43-cb08-47c2-97cd-92666f5e0a48'),(12346,12346,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:58:39','2024-05-24 14:58:39','4a7cb640-d65f-489c-8ba2-b49ee6545269'),(12347,12347,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:39','2024-05-24 14:58:39','ea294fbf-490f-4144-87d5-73c3079fa99b'),(12348,12348,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Targeted Environmental Investigation Checklist for Outbreaks of Invasive Infections Caused by Environmental Fungi\"}',1,'2024-05-24 14:58:39','2024-05-24 14:58:39','9bd8da69-f1e5-4141-86c2-00500ce98bbf'),(12349,12349,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:40','2024-05-24 14:58:40','88bd47b6-9796-4195-801a-a0f6bb41da22'),(12350,12350,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:40','2024-05-24 14:58:40','7e0fc3a2-6d11-456f-b28b-dca6d8ba139e'),(12351,12351,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:40','2024-05-24 14:58:40','e8c8f2aa-3944-4558-8f32-5f8da19c2cc8'),(12352,12352,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:40','2024-05-24 14:58:40','aa890e48-8c9b-489a-bf1c-7b8714d3a315'),(12353,12353,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:40','2024-05-24 14:58:40','50908644-4be9-400f-866c-85a8e18e258b'),(12354,12354,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:58:40','2024-05-24 14:58:40','f57e21ea-348b-43b9-b9f2-3bba530b01cf'),(12355,12355,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:40','2024-05-24 14:58:40','8e844cac-6e84-4295-b186-10948f6c541f'),(12356,12356,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:58:40','2024-05-24 14:58:40','7d397624-fbbf-437c-80e1-a0a06c9a2849'),(12357,12357,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:41','2024-05-24 14:58:41','4cc16705-f333-4a27-ae87-850bc1a157ac'),(12358,12358,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:58:41','2024-05-24 14:58:41','74613d30-2c2a-4a4d-ae09-a249de06f8c2'),(12359,12359,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:41','2024-05-24 14:58:41','b435bed2-3f16-4d26-9785-130a2181fd8d'),(12360,12360,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Targeted Environmental Investigation Checklist for Outbreaks of Invasive Infections Caused by Environmental Fungi\"}',1,'2024-05-24 14:58:41','2024-05-24 14:58:41','f1ef7d5b-98ee-4b0e-97ba-ad1f244e262c'),(12361,12361,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:42','2024-05-24 14:58:42','d3809882-fcfe-4af3-8ad8-aae975e18db3'),(12362,12362,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:42','2024-05-24 14:58:42','20770b40-15bf-4484-af03-2f04974b5c69'),(12363,12363,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:42','2024-05-24 14:58:42','a05d71fe-ae4a-44b7-a05f-246f81068ea4'),(12364,12364,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:42','2024-05-24 14:58:42','7636d73c-239e-45b7-ac53-8afe71db9b2f'),(12365,12365,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:43','2024-05-24 14:58:43','9a9439ce-5820-40e4-a23a-f067c83dfd19'),(12366,12366,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:43','2024-05-24 14:58:43','304d5eeb-72fe-4406-b944-3e70dfcba3ea'),(12367,12367,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:43','2024-05-24 14:58:43','dbed83d3-72ec-43a6-948e-ece0dc1a00ea'),(12368,12368,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:43','2024-05-24 14:58:43','e9ce7399-a6a0-429f-bd07-15bc69c4fdb7'),(12369,12369,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:44','2024-05-24 14:58:44','dfe81044-ce11-452f-96e2-ee9291849a0c'),(12370,12370,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:44','2024-05-24 14:58:44','f7a386fa-eb70-40a1-bbe3-910b63e9b848'),(12371,12371,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:44','2024-05-24 14:58:44','96e79c6a-62f9-4364-9c66-4ea01a9dc4e1'),(12372,12372,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:44','2024-05-24 14:58:44','94792294-41b8-48be-81d3-59d20a1f5b15'),(12373,12373,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:45','2024-05-24 14:58:45','b3d13a15-82c7-448e-bc53-2676da5a95b8'),(12374,12374,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:45','2024-05-24 14:58:45','dc4d86f1-b535-4051-8117-3d7efb533e95'),(12375,12375,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:45','2024-05-24 14:58:45','50f73aea-69d3-4535-9de1-1f4f69086ec4'),(12376,12376,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:45','2024-05-24 14:58:45','d3723e6f-2035-457d-80f0-78b574ee24eb'),(12377,12377,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:46','2024-05-24 14:58:46','3b437f61-2bd5-435e-b41a-3d59e3c7b49f'),(12378,12378,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:46','2024-05-24 14:58:46','bab4238d-87d0-4a15-9e1c-50401b263b2f'),(12379,12379,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:46','2024-05-24 14:58:46','270ed90d-e104-4d59-aa75-c764705cf07f'),(12380,12380,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:46','2024-05-24 14:58:46','831a3f8f-5907-4340-a2f9-f7bfb2ddec3b'),(12381,12381,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:47','2024-05-24 14:58:47','a8156192-c5f0-4c45-a50e-fd00ade8c64a'),(12382,12382,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:47','2024-05-24 14:58:47','8bf2590f-da13-4a2e-a420-d37d0c41709f'),(12383,12383,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:48','2024-05-24 14:58:48','c6d86c77-3fa3-4ab7-9436-653f94d39745'),(12384,12384,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:48','2024-05-24 14:58:48','2e382aba-144f-411b-b03c-28618dd00ab9'),(12385,12385,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:49','2024-05-24 14:58:49','538111bb-bd08-4bbd-85e0-ade41fb2b0a7'),(12386,12386,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:49','2024-05-24 14:58:49','3617eead-62eb-436e-a212-e21261efc146'),(12387,12387,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:49','2024-05-24 14:58:49','cd1cd036-b089-4ad4-a373-b5a8b1f5b2b8'),(12388,12388,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:49','2024-05-24 14:58:49','3b19fa86-a3f4-4c04-bce7-845fcc5e583d'),(12389,12389,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:50','2024-05-24 14:58:50','ab43b235-7b00-419a-a13d-af84090e2b58'),(12390,12390,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:50','2024-05-24 14:58:50','e2254d0a-fa3b-46f3-a087-1506bab4b56f'),(12391,12391,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:50','2024-05-24 14:58:50','db486ffb-ad42-4ad4-9f68-882ba9830ce8'),(12392,12392,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:50','2024-05-24 14:58:50','f2d4584f-a003-4167-afff-49cb61d4ec81'),(12393,12393,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:52','2024-05-24 14:58:52','f3cd1428-9947-4ada-b90b-d12f9e733484'),(12394,12394,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:52','2024-05-24 14:58:52','dd04d732-6b36-4c36-b754-1476ad968668'),(12395,12395,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:52','2024-05-24 14:58:52','b5cadce9-2ee3-4940-a5e2-a449787888ad'),(12396,12396,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:52','2024-05-24 14:58:52','f699569f-0d5a-4319-8baa-d6d2924a2fb6'),(12397,12397,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:53','2024-05-24 14:58:53','63994ec8-b011-4f42-8e0b-26859daaf199'),(12398,12398,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:53','2024-05-24 14:58:53','05e77bc2-78ef-4d9f-8003-dd5cffe8e6ef'),(12399,12399,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:53','2024-05-24 14:58:53','0516b1cc-2be1-4e47-a6e5-b6923243cf39'),(12400,12400,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:53','2024-05-24 14:58:53','af1b34d7-65fe-4d65-93b9-00c80f73bd0e'),(12401,12401,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:55','2024-05-24 14:58:55','541a1b88-337a-4d84-a365-0cb52cda01de'),(12402,12402,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:55','2024-05-24 14:58:55','670e0db5-8b56-4e26-adca-57afb4a3c468'),(12403,12403,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:55','2024-05-24 14:58:55','12993c7c-fcd2-4492-8d99-0e2557d93198'),(12404,12404,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:55','2024-05-24 14:58:55','998702a6-a769-4279-953f-1c6951596919'),(12405,12405,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:55','2024-05-24 14:58:55','ce574eba-36bb-49ec-b46c-01d2433beb26'),(12406,12406,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:58:55','2024-05-24 14:58:55','311056cd-fcd2-4816-bf06-e40e30d16cbc'),(12407,12407,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:55','2024-05-24 14:58:55','a9e7b564-2d64-4d02-b3ef-9f1b035d8acf'),(12408,12408,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:58:55','2024-05-24 14:58:55','b84d999b-2ea2-4d8b-b24e-84fd1cde4511'),(12409,12409,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:55','2024-05-24 14:58:55','a02f6db6-3983-430c-a51c-06dacb08be8b'),(12410,12410,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:58:55','2024-05-24 14:58:55','3630a9e0-7d34-4d39-862d-e4626c693223'),(12411,12411,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:55','2024-05-24 14:58:55','987cc377-26e8-4281-80a5-908ca71042d0'),(12412,12412,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Targeted Environmental Investigation Checklist for Outbreaks of Invasive Infections Caused by Environmental Fungi\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/pdf/targeted-environmental-investigation-checklist-508.pdf\"}',1,'2024-05-24 14:58:55','2024-05-24 14:58:55','b4fba103-dff9-494c-ba7a-5252d0bbb3dc'),(12413,12413,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:56','2024-05-24 14:58:56','69592d87-41ad-4d00-a6d0-80a07ec5724c'),(12414,12414,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:56','2024-05-24 14:58:56','5f8b5ca4-8fb4-4300-ae18-4c9e7a5e09fd'),(12415,12415,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:56','2024-05-24 14:58:56','f94639aa-bdf4-4738-a24e-0f12db0aca8a'),(12416,12416,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:56','2024-05-24 14:58:56','71a3ebbd-4ecb-4173-82cf-55f3ced7d8a0'),(12417,12417,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:57','2024-05-24 14:58:57','1420d211-c13e-4de8-8d82-fa4a00de2c48'),(12418,12418,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:57','2024-05-24 14:58:57','a8ec4f0c-edc8-4818-8413-657a972d26ad'),(12419,12419,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:57','2024-05-24 14:58:57','ed3048ff-18b7-477e-a87d-339fae977633'),(12420,12420,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:57','2024-05-24 14:58:57','8a5eeee5-6787-45e0-a95a-a50c5bd3edb3'),(12421,12421,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:59','2024-05-24 14:58:59','f996b585-cf14-4715-8dc5-302383014e58'),(12422,12422,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:58:59','2024-05-24 14:58:59','fe2966e5-0aa7-428c-884e-63c29ef5b187'),(12423,12423,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:58:59','2024-05-24 14:58:59','53b8fdc2-e780-4cb4-b14a-b674d97be32c'),(12424,12424,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:58:59','2024-05-24 14:58:59','3e723fdf-bc6f-4e9f-aaae-91ccf14fb7a7'),(12425,12425,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:00','2024-05-24 14:59:00','00313835-90ce-4461-8db2-7124160479c0'),(12426,12426,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:00','2024-05-24 14:59:00','0730ee88-7566-42a6-9ec7-5e64d140db64'),(12427,12427,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:00','2024-05-24 14:59:00','5e05f532-8c43-4e5a-a89d-099af22bccbb'),(12428,12428,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:00','2024-05-24 14:59:00','5536ad91-5d66-4423-bac1-3301e97c813b'),(12429,12429,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:00','2024-05-24 14:59:00','bff26d5a-ee2c-4c49-9957-e04c5a2939dc'),(12430,12430,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health, Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/health-professionals.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\"}',1,'2024-05-24 14:59:00','2024-05-24 14:59:00','47cc4a27-12ab-4dc1-b166-b2a5382ce91d'),(12431,12431,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:00','2024-05-24 14:59:00','79e3e079-967b-4787-939a-cc0baecb388c'),(12432,12432,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\"}',1,'2024-05-24 14:59:00','2024-05-24 14:59:00','0bedb9e2-ef5f-475a-ad20-8f0360ab7950'),(12433,12433,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:00','2024-05-24 14:59:00','d8b1ab82-200a-4819-9320-c529406e70f3'),(12434,12434,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\"}',1,'2024-05-24 14:59:00','2024-05-24 14:59:00','14723dfb-2143-45bb-950f-32a9dc5d6725'),(12435,12435,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:00','2024-05-24 14:59:00','fbed8cca-549d-4012-889d-9350850f82fc'),(12436,12436,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Targeted Environmental Investigation Checklist for Outbreaks of Invasive Infections Caused by Environmental Fungi\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/pdf/targeted-environmental-investigation-checklist-508.pdf\"}',1,'2024-05-24 14:59:00','2024-05-24 14:59:00','83056c0a-d02b-422b-a53e-f7508c937942'),(12437,12437,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:02','2024-05-24 14:59:02','e959ad34-b952-49f3-b92b-d4bd29abba77'),(12438,12438,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:02','2024-05-24 14:59:02','f0710727-9e26-4778-af19-88e4e998ec42'),(12439,12439,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:02','2024-05-24 14:59:02','140d63bd-4dad-4b21-bfc4-ed9fa07cbe39'),(12440,12440,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:02','2024-05-24 14:59:02','b7ca20b6-780f-47da-9960-fc42431278f8'),(12441,12441,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:03','2024-05-24 14:59:03','675b75a9-a7a0-4117-9e2c-73e811ea043b'),(12442,12442,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:03','2024-05-24 14:59:03','06721187-7025-4035-bb47-3b90bbd1874d'),(12443,12443,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:03','2024-05-24 14:59:03','763e9d31-7b2c-4951-8e55-146c03e98d6a'),(12444,12444,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:03','2024-05-24 14:59:03','08e75b78-720c-4492-9696-02d655582ed5'),(12445,12445,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:04','2024-05-24 14:59:04','9d997ecd-0dfe-4848-aab3-23cc90ccf1ad'),(12446,12446,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:04','2024-05-24 14:59:04','6839142f-a845-4b36-9290-169d49f593bf'),(12447,12447,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:04','2024-05-24 14:59:04','32c6364c-4e42-477c-bf36-8db351b78ffa'),(12448,12448,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:04','2024-05-24 14:59:04','88b792fe-8831-4663-abb7-8c56d0ba891b'),(12449,12449,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:06','2024-05-24 14:59:06','3e3e1707-f5df-48ca-adad-e6eb32e05e18'),(12450,12450,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:06','2024-05-24 14:59:06','17ddf6bd-23d8-4d34-8889-73cb582fc82a'),(12451,12451,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:06','2024-05-24 14:59:06','e74a7172-17bd-4a16-99d8-94447a2bf8ab'),(12452,12452,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:06','2024-05-24 14:59:06','5d8e4eeb-7582-443f-9570-a0d97151264e'),(12453,12453,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:07','2024-05-24 14:59:07','8fb49472-5602-4320-b11a-b4b5fdbb0bdc'),(12454,12454,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:07','2024-05-24 14:59:07','9359c75c-4709-4d90-a923-8ef4d46a7a8f'),(12455,12455,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:07','2024-05-24 14:59:07','3a8e545c-8f57-4b90-99e5-80c0c8ae366c'),(12456,12456,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:07','2024-05-24 14:59:07','49dd3475-0c37-4261-859a-c10dacf0665d'),(12457,12457,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:08','2024-05-24 14:59:08','f95d7979-f75d-4339-bfe9-e3dd8dd7cac1'),(12458,12458,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:08','2024-05-24 14:59:08','8e57ca5e-a379-4dc5-af01-4a90dd7ea459'),(12459,12459,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:08','2024-05-24 14:59:08','b2d07b8b-820c-42c2-8971-7ab4330e95fc'),(12460,12460,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:08','2024-05-24 14:59:08','8da7b421-5be3-4a0d-8d20-d3777ae7d0e4'),(12461,12461,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:09','2024-05-24 14:59:09','314cb9ee-8aa0-4899-9243-010fe0d7b83f'),(12462,12462,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:09','2024-05-24 14:59:09','2fe97307-5d00-44ba-8e5b-ff2f23ee8523'),(12463,12463,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:09','2024-05-24 14:59:09','57600848-4f07-41db-a629-b5adeb3f831e'),(12464,12464,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:09','2024-05-24 14:59:09','da579109-fcc3-4403-9e03-9631e854dcb0'),(12465,12465,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:10','2024-05-24 14:59:10','5a6c0b12-ea6d-46f6-a2c1-e2ae865fc231'),(12466,12466,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:10','2024-05-24 14:59:10','19ba8f22-b671-4442-bfc4-d923539c1e15'),(12467,12467,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:10','2024-05-24 14:59:10','2e5f8056-1b23-4227-9bba-12fd335b41ae'),(12468,12468,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:10','2024-05-24 14:59:10','c62230f4-32fd-4b7b-a029-7c89bd32144a'),(12469,12469,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:10','2024-05-24 14:59:10','32e1402d-1950-4f71-aacd-9afefd413127'),(12470,12470,1,NULL,'__temp_skhlvkcmjvxiqsezdccjtzcfvqxhnswwalhz',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page provides specific recommended actions for both public health and healthcare personnel responding to fungal disease outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 14:59:10','2024-06-13 13:51:37','590512a7-c4b8-4f21-b8a3-ded5cc7912ae'),(12471,12471,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:10','2024-05-24 14:59:10','c95da0b7-8761-43be-b084-b6f6f3106dd3'),(12472,12472,1,NULL,'__temp_bfvgcsfocondpghwdprtquqthyxnbcajoktr',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Healthcare-Associated Mold Outbreak Information\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/mold-healthcare.html?CDC_AAref_Val=https://www.cdc.gov/fungal/outbreaks/healthcare-associated-mold-outbreaks.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes general information and frequently-asked questions pertaining to mold outbreaks in healthcare settings. It also includes contact information for requesting direct consultation and support from CDC.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 14:59:10','2024-06-13 13:51:37','ca5080c2-2201-4b9a-baaa-f54c8a51c3ff'),(12473,12473,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:11','2024-05-24 14:59:11','a0f71b43-816f-47ea-9eab-f7c4cae7df29'),(12474,12474,1,NULL,'__temp_whdpgwlyywqsuixvitiotuuuzikkcbprobfn',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A Guide to Investigating Suspected Outbreaks of Mucormycosis in Healthcare\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787571/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This publication provides an overview of key challenges and response measures related to investigating Mucormycosis in Healthcare settings. The included information may be applicable to other environmental fungi, such as Aspergillus.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 14:59:11','2024-06-13 13:51:37','5b23287a-fb69-482e-bc48-bdea87b9f031'),(12475,12475,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:11','2024-05-24 14:59:11','08648c63-e7af-4752-a1cc-5bb967ebb752'),(12476,12476,1,NULL,'__temp_mqnavntnumgwliikwgkpmttieemiyejdymge',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Targeted Environmental Investigation Checklist for Outbreaks of Invasive Infections Caused by Environmental Fungi\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/pdf/targeted-environmental-investigation-checklist-508.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This tool is intended to aid in performing an environmental assessment when investigating healthcare-associated disease outbreaks caused by environmental fungi (e.g., Aspergillus spp. and mucormycetes). Not all of sections of this checklist will pertain to every investigation.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 14:59:11','2024-06-13 13:51:37','4183d2e5-c611-44b9-8030-c47c975f63c5'),(12477,12477,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:12','2024-05-24 14:59:12','b8836099-c4a3-4d17-bafa-789237c07c9f'),(12478,12478,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:12','2024-05-24 14:59:12','ce816c63-440a-4138-8a72-de76c2a93c5f'),(12479,12479,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:12','2024-05-24 14:59:12','47a7aa24-19d0-40b3-a61e-179950042926'),(12480,12480,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:12','2024-05-24 14:59:12','fc04d078-c35a-4f40-97f0-df357deee1db'),(12481,12481,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:13','2024-05-24 14:59:13','53722e6d-0f02-4b2e-bac3-65647fb9ea34'),(12482,12482,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:13','2024-05-24 14:59:13','5f8fceab-14c3-4ddd-bfeb-49009ee49296'),(12483,12483,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:13','2024-05-24 14:59:13','6275b990-dabf-4e62-ac32-d8cf5c970b87'),(12484,12484,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:13','2024-05-24 14:59:13','7af39d24-a533-4e50-873b-43ca7548d106'),(12485,12485,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:15','2024-05-24 14:59:15','b5dc4463-fa9c-4565-8bf1-60fb2b80f308'),(12486,12486,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:15','2024-05-24 14:59:15','8b597fc1-604a-430a-92fc-afa5b81b8c69'),(12487,12487,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:15','2024-05-24 14:59:15','b71e0e4c-fd4f-4cad-a4d5-ef4bb293cbe9'),(12488,12488,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:15','2024-05-24 14:59:15','ac4e43ec-8652-4fc5-b998-8b49cd4af251'),(12489,12489,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:16','2024-05-24 14:59:16','5794bdf5-81aa-4f04-b130-fe282f1a5bf7'),(12490,12490,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:16','2024-05-24 14:59:16','84615b85-15cc-4bc2-8a93-3eeec2959982'),(12491,12491,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:16','2024-05-24 14:59:16','0acf721c-6b9d-47cf-b702-523cc01ff78e'),(12492,12492,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:16','2024-05-24 14:59:16','4296c5c3-7e2a-412a-bec1-adce69fe6e29'),(12493,12493,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:18','2024-05-24 14:59:18','abfed7a0-2536-4ce5-95cc-8b0b198d1e2a'),(12494,12494,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:18','2024-05-24 14:59:18','d76f9339-e9c6-4962-badc-10661ecbf21b'),(12495,12495,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:18','2024-05-24 14:59:18','7d567b33-07e5-4cfe-b248-6246d7263251'),(12496,12496,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:18','2024-05-24 14:59:18','0827b136-2a4a-4078-afa5-194a2f25159d'),(12497,12497,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:19','2024-05-24 14:59:19','2f6e7ca1-d1ee-4658-ad9a-f6a816eaabe0'),(12498,12498,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:19','2024-05-24 14:59:19','2258b717-2ce0-42f6-baba-4ae06a5141d5'),(12499,12499,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:19','2024-05-24 14:59:19','2a384f3b-ca56-4ee1-93c2-d797a26ff497'),(12500,12500,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:19','2024-05-24 14:59:19','ebf3f3dc-4337-449e-9761-c6f66dbd2af5'),(12501,12501,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:20','2024-05-24 14:59:20','6db5b3ca-a675-4d68-8d75-87d3f0ce4c12'),(12502,12502,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:20','2024-05-24 14:59:20','e4833d59-1130-43cb-8246-18dd36928bc2'),(12503,12503,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:20','2024-05-24 14:59:20','5e1b6980-c555-4970-bf14-5f2c725897d8'),(12504,12504,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:20','2024-05-24 14:59:20','d9864883-6922-40d6-8cee-91221fee54fd'),(12505,12505,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:21','2024-05-24 14:59:21','f92744ef-a836-42de-bd99-2b107f18d817'),(12506,12506,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:21','2024-05-24 14:59:21','a29598ad-34ac-4aea-9689-603f9325fdfb'),(12507,12507,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:22','2024-05-24 14:59:22','09208425-fa64-4010-877f-2715e5ac4177'),(12508,12508,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:22','2024-05-24 14:59:22','212669a9-eaaa-4f70-80a6-5c942eee2317'),(12509,12509,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:23','2024-05-24 14:59:23','099946e5-9467-4b40-8ced-4a7771e4a0c2'),(12510,12510,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:23','2024-05-24 14:59:23','2d545c70-e38c-46d7-a83d-c52e03a1d0d4'),(12511,12511,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:23','2024-05-24 14:59:23','cf40b990-00d3-44d7-8a6a-1c207e95d2aa'),(12512,12512,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:23','2024-05-24 14:59:23','edbedf1e-43b0-4a4a-b85e-2466e54214e4'),(12513,12513,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:26','2024-05-24 14:59:26','f0fc0aac-6a6c-4657-96b7-879373acbab6'),(12514,12514,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:26','2024-05-24 14:59:26','c9a28f4f-3374-4d9b-a7ed-cedcdb84256c'),(12515,12515,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:26','2024-05-24 14:59:26','0069b222-88b1-4839-9823-e8adbda764f6'),(12516,12516,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:26','2024-05-24 14:59:26','293a4058-faf6-49b0-8c25-dd74378b91e8'),(12517,12517,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:27','2024-05-24 14:59:27','bd0c8047-6b29-4dce-bf12-ff7fe35df3aa'),(12518,12518,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:27','2024-05-24 14:59:27','145844ee-84c0-4251-b598-9bab2d8b2a19'),(12519,12519,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:27','2024-05-24 14:59:27','6a829652-d678-4191-80c0-f1beb6fe375b'),(12520,12520,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:27','2024-05-24 14:59:27','9c415f61-3427-4838-a6f5-3491a1c84e5d'),(12521,12521,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:28','2024-05-24 14:59:28','ae59569d-67e0-4e38-b223-17f797a1141e'),(12522,12522,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:28','2024-05-24 14:59:28','542e3839-85af-4394-a088-e12885df0a57'),(12523,12523,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:28','2024-05-24 14:59:28','1713d391-ea07-4c47-a458-d6183f7b4635'),(12524,12524,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:28','2024-05-24 14:59:28','5cd3fefc-a4bd-4a3d-8a52-e30c436d079f'),(12525,12525,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:29','2024-05-24 14:59:29','18325318-917d-46f3-ab63-9980cdd4e4bb'),(12526,12526,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:30','2024-05-24 14:59:30','ea878119-ccf7-4aa1-a24c-7c8893b2b141'),(12527,12527,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:30','2024-05-24 14:59:30','1a11d64b-4f51-48ce-9638-ec7e9dec10e5'),(12528,12528,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:30','2024-05-24 14:59:30','86250c43-00e5-473b-a885-af98eb5ffc86'),(12529,12529,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:31','2024-05-24 14:59:31','35e6f2ae-e09f-43dd-8b30-851175c0e05b'),(12530,12530,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:31','2024-05-24 14:59:31','b12e89db-5b66-402e-888e-55d36da19557'),(12531,12531,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:31','2024-05-24 14:59:31','a7b09624-b9f4-456d-922c-3c6d904fd0c3'),(12532,12532,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:31','2024-05-24 14:59:31','8dafb083-672a-448a-bf7b-0a647074b718'),(12533,12533,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:32','2024-05-24 14:59:32','62873979-4cc5-45a7-9b23-5ed7c5c2be43'),(12534,12534,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:32','2024-05-24 14:59:32','a9ddb558-841a-4c1b-b993-e218ca507780'),(12535,12535,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:32','2024-05-24 14:59:32','7b89c8b2-526e-40ad-89b3-64a787fb98d3'),(12536,12536,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:32','2024-05-24 14:59:32','09b9b803-bae6-4731-a876-de69baccbf94'),(12537,12537,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:34','2024-05-24 14:59:34','3b242932-d59e-4319-963f-d43cb8da6467'),(12538,12538,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:34','2024-05-24 14:59:34','54b2e372-9413-4330-a622-eec60b9573a2'),(12539,12539,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:34','2024-05-24 14:59:34','16506d87-b05f-4eb4-bfd6-3df85ad2c50a'),(12540,12540,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:34','2024-05-24 14:59:34','f140ceda-8e05-4fa0-a6f1-dc13b79f3031'),(12541,12541,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:35','2024-05-24 14:59:35','28c401d2-0707-41e0-b985-cb1be81756dd'),(12542,12542,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:35','2024-05-24 14:59:35','21dc4d6e-6d26-4454-910f-4bbd6f9ebf9c'),(12543,12543,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:35','2024-05-24 14:59:35','67a5a819-5a93-4c81-97cf-5f8949f54c96'),(12544,12544,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:35','2024-05-24 14:59:35','f347fdaf-8e75-46c5-a8ae-8bcfa3e5946a'),(12545,12545,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:36','2024-05-24 14:59:36','846757d7-2dc4-4235-bfdc-bb43a98493a4'),(12546,12546,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:36','2024-05-24 14:59:36','db9822a2-e437-4f21-8c99-8b1130043ee5'),(12547,12547,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:36','2024-05-24 14:59:36','3edf25bb-01c8-454f-8ff1-df8aa6d13b9b'),(12548,12548,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:36','2024-05-24 14:59:36','3a87514a-800a-4497-93ce-b500bd0eaf80'),(12549,12549,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:38','2024-05-24 14:59:38','a4762a5a-fe37-41ad-8583-36e41bb77bdc'),(12550,12550,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:38','2024-05-24 14:59:38','ab80a618-09de-4cdb-9508-b025a9f683c0'),(12551,12551,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:38','2024-05-24 14:59:38','a83be3bd-c0bd-49b9-94d1-8b5265ded41a'),(12552,12552,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:38','2024-05-24 14:59:38','5589ba64-5e38-4b7e-8b8e-2a6121aeb9e9'),(12553,12553,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:39','2024-05-24 14:59:39','67c749cd-5899-4d47-ad6d-8c20215bf591'),(12554,12554,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:39','2024-05-24 14:59:39','a9192a6c-9122-42e2-bef2-9bf23d8edc53'),(12555,12555,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:39','2024-05-24 14:59:39','b5e3438a-e0d2-4271-b32e-4882e990b7e0'),(12556,12556,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:39','2024-05-24 14:59:39','5505cfa6-a923-4934-af83-d21d1dd711ab'),(12557,12557,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:41','2024-05-24 14:59:41','38ac701b-5a92-430e-8532-eda1954c8b78'),(12558,12558,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:41','2024-05-24 14:59:41','b17ff08b-8592-4894-9994-8adc165f01d5'),(12559,12559,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:41','2024-05-24 14:59:41','9554c798-2ca1-472f-b42c-90ec899e2c18'),(12560,12560,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:41','2024-05-24 14:59:41','b343e989-b334-48ee-838f-3570719f283f'),(12561,12561,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:42','2024-05-24 14:59:42','d3fdc63c-691c-4d07-bcc7-c12efff4a60f'),(12562,12562,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:42','2024-05-24 14:59:42','30d08f6f-061e-45ba-bab3-79265d11e797'),(12563,12563,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:42','2024-05-24 14:59:42','3e584f03-fc00-4016-be57-90eb439fde75'),(12564,12564,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:42','2024-05-24 14:59:42','680d7f36-2c95-49b5-a73e-03d0307444b1'),(12565,12565,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:43','2024-05-24 14:59:43','ad3bc180-95fe-462f-8db0-1b688a15ab93'),(12566,12566,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:43','2024-05-24 14:59:43','ef2b1019-e7cf-4df5-9e63-25e998e87340'),(12567,12567,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:44','2024-05-24 14:59:44','23f1eac2-357f-4d5f-8f3b-838081e53f8e'),(12568,12568,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:44','2024-05-24 14:59:44','752d1d53-f230-4ee3-9401-7a7342d9ee1f'),(12569,12569,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:45','2024-05-24 14:59:45','3e5795e7-53e6-4829-9a3e-7f9f36607c8b'),(12570,12570,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:45','2024-05-24 14:59:45','922a007d-44df-478e-9a3b-fbe03a5a4308'),(12571,12571,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:45','2024-05-24 14:59:45','97713a59-40d5-499a-b4a0-7a77249ad5bf'),(12572,12572,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:45','2024-05-24 14:59:45','6787630e-4adf-418d-b2a6-e9ff16927985'),(12573,12573,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:46','2024-05-24 14:59:46','8ac58fab-45a2-4e5e-9ce4-938a782bad9a'),(12574,12574,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:46','2024-05-24 14:59:46','bbab18dc-fdda-46ab-97e0-a42571b7b434'),(12575,12575,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:46','2024-05-24 14:59:46','2d70a237-5552-4e9d-9288-5b8ceab918b6'),(12576,12576,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:46','2024-05-24 14:59:46','40fedca5-2834-4540-8b46-6ecfd436cc0b'),(12577,12577,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:47','2024-05-24 14:59:47','28c61c3b-79e1-4dd3-ad82-fb814619d217'),(12578,12578,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:47','2024-05-24 14:59:47','ad2a3cfc-5617-4212-8d8d-dd415c2b286b'),(12579,12579,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:47','2024-05-24 14:59:47','35d722e3-7017-45b4-be73-5e2fb8159271'),(12580,12580,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:47','2024-05-24 14:59:47','0b4b28cb-77a3-47cb-b32e-456cb2b21d06'),(12581,12581,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:49','2024-05-24 14:59:49','dbedccba-3e88-4b63-b2b8-031fa250b53a'),(12582,12582,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:49','2024-05-24 14:59:49','d26b0ee4-1a2a-4404-8f7e-5d3f031950be'),(12583,12583,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:49','2024-05-24 14:59:49','15188ce7-cd27-4525-9ce8-260f35ec4a8c'),(12584,12584,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:49','2024-05-24 14:59:49','808e7fd4-6dd0-4e0e-8117-79345069129d'),(12585,12585,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:50','2024-05-24 14:59:50','799f0591-e8b2-45f2-a695-31d97c51c3d9'),(12586,12586,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:50','2024-05-24 14:59:50','e432e5eb-d0b2-4fff-9940-594176aeafb0'),(12587,12587,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:50','2024-05-24 14:59:50','420b2b27-48c4-41aa-852f-408f73a48fb2'),(12588,12588,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:50','2024-05-24 14:59:50','df979fdd-2da0-4966-b98e-646730d12806'),(12589,12589,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:51','2024-05-24 14:59:51','b075e4c1-3586-432b-b4cf-78651a755c5d'),(12590,12590,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:51','2024-05-24 14:59:51','57c1d0fc-8004-4198-9cfd-9fdf74160c4a'),(12591,12591,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:51','2024-05-24 14:59:51','ae190bdf-bd2c-41be-a31b-1db34a275866'),(12592,12592,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:51','2024-05-24 14:59:51','3f830181-15ef-48cc-8495-ed077ed75500'),(12593,12593,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:52','2024-05-24 14:59:52','2d7f37a5-ecd7-48e0-be22-2f5fbd8174f1'),(12594,12594,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:52','2024-05-24 14:59:52','0d2c6e82-739c-462e-8f90-737e879ea6fc'),(12595,12595,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:52','2024-05-24 14:59:52','ed7ebbdc-d901-4a35-9161-670cf9da7701'),(12596,12596,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:52','2024-05-24 14:59:52','9c274c3f-654a-4566-a9ac-bed0e2c765a6'),(12597,12597,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:54','2024-05-24 14:59:54','0c58037a-1c4f-4591-b1fc-1823048daa97'),(12598,12598,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:54','2024-05-24 14:59:54','94d62200-35e4-4d16-903e-a7809a9a10f8'),(12599,12599,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:54','2024-05-24 14:59:54','f23a3782-85aa-4cc2-9bd4-1cf23143dd4a'),(12600,12600,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:54','2024-05-24 14:59:54','691770c3-fe3e-4306-8726-c8125220d2b7'),(12601,12601,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:55','2024-05-24 14:59:55','3e397c41-0d8e-4306-b617-b4f5b49fc685'),(12602,12602,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:55','2024-05-24 14:59:55','9c8c6c27-5d61-4163-ab92-67a34f3bf6e6'),(12603,12603,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:55','2024-05-24 14:59:55','d07f50b3-698e-45c5-ac0e-d1790f0a9e96'),(12604,12604,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:55','2024-05-24 14:59:55','300d1ab7-7c2e-42cb-8ca9-99fe0ad79036'),(12605,12605,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:56','2024-05-24 14:59:56','836b03bb-1d92-4eca-926c-2089c558c910'),(12606,12606,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:56','2024-05-24 14:59:56','baaaefaa-cfee-40f1-afb9-ccbebdb19e72'),(12607,12607,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:56','2024-05-24 14:59:56','b1b27d1f-f90a-4912-8481-46353e295f99'),(12608,12608,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:56','2024-05-24 14:59:56','d6b90bde-cf5f-42e9-9f47-09b58859c05c'),(12609,12609,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:57','2024-05-24 14:59:57','fc1236d2-7860-4773-a5ae-dff086ab1f8f'),(12610,12610,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:57','2024-05-24 14:59:57','fb204c6e-0b0a-4dd1-93d2-bfef01173ac5'),(12611,12611,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:57','2024-05-24 14:59:57','ee4cd9ba-6c15-4c0a-8bbf-dd9c14c75a04'),(12612,12612,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:57','2024-05-24 14:59:57','54b75363-d9e3-489a-833f-5f5e460392f1'),(12613,12613,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:58','2024-05-24 14:59:58','5d205ef2-4705-48a4-b98f-0f7055dc7255'),(12614,12614,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:59:58','2024-05-24 14:59:58','29b922c2-8e9d-49a6-b742-43787c5e68e8'),(12615,12615,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:59:58','2024-05-24 14:59:58','39ca0fa2-5475-494c-a87b-e0cdb37192bb'),(12616,12616,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:59:58','2024-05-24 14:59:58','5cdb4705-0cd3-4a3d-80f9-f03d8742df4d'),(12617,12617,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:00:00','2024-05-24 15:00:00','0766307f-b53e-4999-bbed-5fe783cba44f'),(12618,12618,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 15:00:00','2024-06-10 19:49:07','2df7b603-8281-4d4b-bb53-7cd344f6b6dd'),(12619,12619,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:00:00','2024-05-24 15:00:00','7ced0970-482c-4587-aa6f-5813f1407553'),(12620,12620,1,NULL,'__temp_mkkgvldnmfnmbqhhomxoyyeihbugmdckqydf',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 15:00:00','2024-06-13 13:35:41','fca28d7b-5d29-4657-870c-aa4f1beb432c'),(12621,12621,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:01:29','2024-05-24 15:01:29','40090f5e-d988-47c5-ac4a-4ff8ce5a7019'),(12622,12622,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 15:01:29','2024-05-24 15:01:29','f786bf7c-46e3-4380-991c-fec0893648eb'),(12623,12623,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:01:38','2024-05-24 15:01:38','6145e186-a4a4-47e4-af38-e5f2aaa6cb3a'),(12624,12624,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\"}',1,'2024-05-24 15:01:38','2024-05-24 15:01:38','e100056f-f9b3-4beb-934b-6b85d2cecacc'),(12625,12625,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:01:41','2024-05-24 15:01:41','f89eb0f2-0748-4d1c-b44a-18203e999947'),(12626,12626,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\"}',1,'2024-05-24 15:01:41','2024-05-24 15:01:41','6be13ea2-4b6a-44d4-ba06-94fe703a52c6'),(12627,12627,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:01:51','2024-05-24 15:01:51','ad389bf7-53dc-4916-a5d7-bd87e75d5883'),(12628,12628,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://Sample+Line+List\"}',1,'2024-05-24 15:01:51','2024-05-24 15:01:51','1e3c15ed-08db-4148-a798-ca91efd63ad1'),(12629,12629,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:01:51','2024-05-24 15:01:51','a5bfcd46-0a1a-4d29-9c95-e3a4b9a90da9'),(12630,12630,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\"}',1,'2024-05-24 15:01:51','2024-05-24 15:01:51','f2b6c928-0b4b-4ba8-ab89-021f829a07ed'),(12631,12631,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:01:57','2024-05-24 15:01:57','0442ff34-0054-4c55-9a5f-5ee7f0dfce9c'),(12632,12632,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\"}',1,'2024-05-24 15:01:57','2024-05-24 15:01:57','ec4d5d70-c610-4a22-94fe-16fde51f96f9'),(12633,12633,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:07:32','2024-05-24 15:07:32','840c6517-60e3-46e3-82bc-a177b860f143'),(12634,12634,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\"}',1,'2024-05-24 15:07:32','2024-05-24 15:07:32','f2860a8d-57a2-4560-a0da-bca84a8bc808'),(12635,12635,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:07:35','2024-05-24 15:07:35','73be4115-fc90-45ef-b930-478f412ffb90'),(12636,12636,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\"}',1,'2024-05-24 15:07:35','2024-05-24 15:07:35','7e6e6342-5477-4889-9fc4-c26d6558c697'),(12637,12637,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:07:41','2024-05-24 15:07:41','f2909cd8-6953-4ac2-9b91-265b83427a31'),(12638,12638,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks.\"}',1,'2024-05-24 15:07:41','2024-05-24 15:07:41','e39633c8-a75f-4dc2-aa0c-703692255171'),(12639,12639,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:09','2024-05-24 15:08:09','b448acb0-18d6-47ce-b3d0-07b9d9959247'),(12640,12640,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:08:09','2024-05-24 15:08:09','5307c1ee-a579-4034-bd6f-5d8b9c2ede09'),(12641,12641,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:24','2024-05-24 15:08:24','0690de61-ad05-4e54-847d-50c9451ad7fc'),(12642,12642,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:08:24','2024-05-24 15:08:24','6199ebda-0851-4ca9-8a3a-97832b57cdb0'),(12643,12643,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:24','2024-05-24 15:08:24','52c19817-7096-46b7-9dc7-66ff6a94d7a6'),(12644,12644,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 15:08:24','2024-05-24 15:08:24','6f1f99e5-9b29-43a3-981b-ea05d5c8e298'),(12645,12645,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:32','2024-05-24 15:08:32','5e16651b-1ec1-4ffb-8170-1d9c2e9acfd2'),(12646,12646,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:08:32','2024-05-24 15:08:32','5d1ec852-7911-4655-be9a-4f63b456bb8b'),(12647,12647,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:32','2024-05-24 15:08:32','f0bd3612-cb85-4b4e-9af6-1ec65375746c'),(12648,12648,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\"}',1,'2024-05-24 15:08:32','2024-05-24 15:08:32','ac4ea9d1-63e3-4ea1-9b9d-de7343ab9765'),(12649,12649,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:36','2024-05-24 15:08:36','3f46f3e2-1e68-4663-8643-2d9990326c25'),(12650,12650,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:08:36','2024-05-24 15:08:36','87d05346-2114-4620-aa0b-721ed00641ed'),(12651,12651,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:36','2024-05-24 15:08:36','9c4876d3-1fae-47fe-826e-c16f24e89dae'),(12652,12652,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\"}',1,'2024-05-24 15:08:36','2024-05-24 15:08:36','dc2154e1-d6fb-4b1d-8acc-cefe7e96fd26'),(12653,12653,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:40','2024-05-24 15:08:40','72c15058-9ed4-4fcc-800c-ac4fa367fe19'),(12654,12654,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:08:40','2024-05-24 15:08:40','23b05222-2aa0-4ed5-9c84-0b55070f4097'),(12655,12655,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:40','2024-05-24 15:08:40','1d074654-529b-43e6-89a0-5680ee842977'),(12656,12656,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\"}',1,'2024-05-24 15:08:40','2024-05-24 15:08:40','a327d897-32cf-4f97-be9e-08c9b28971e5'),(12657,12657,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:47','2024-05-24 15:08:47','72647533-1e9f-49b4-9fb4-3f331269d961'),(12658,12658,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:08:47','2024-05-24 15:08:47','3db442a0-5b20-4afa-ad64-a79abe40a313'),(12659,12659,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:47','2024-05-24 15:08:47','a17f9874-4917-43bf-85d8-0c1a16ddbcdc'),(12660,12660,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\"}',1,'2024-05-24 15:08:47','2024-05-24 15:08:47','8f6ecf57-5c5e-4c43-b602-f706bbae59e0'),(12661,12661,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:48','2024-05-24 15:08:48','24be0566-93e0-40ef-b521-6c2e27169b3a'),(12662,12662,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:08:48','2024-05-24 15:08:48','b8ea11a7-d233-4831-ae53-824022b5a9a0'),(12663,12663,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:48','2024-05-24 15:08:48','72bc1481-62bc-41ac-b5ed-3e29658e02e0'),(12664,12664,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\"}',1,'2024-05-24 15:08:48','2024-05-24 15:08:48','7b6e14f3-51f9-4c47-bc5b-88a2915d632f'),(12665,12665,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:57','2024-05-24 15:08:57','19a39bb0-e1e4-4b94-b99b-7cad111de42a'),(12666,12666,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:08:57','2024-05-24 15:08:57','a9f111ab-d997-4c8f-9e80-f1332c893112'),(12667,12667,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:08:57','2024-05-24 15:08:57','ac4dda04-756f-4d87-898e-f85968c63c3e'),(12668,12668,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:08:57','2024-05-24 15:08:57','57e3cf4f-a388-4791-a826-f599f4d525be'),(12669,12669,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:00','2024-05-24 15:09:00','c7e03c26-71ba-4bf9-be83-07f7d7fe2e2e'),(12670,12670,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:09:00','2024-05-24 15:09:00','e6653b40-a6a3-4a2e-9f1e-390f26e87920'),(12671,12671,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:00','2024-05-24 15:09:00','0fbd1e48-3dcd-4f39-9858-9e91a611c430'),(12672,12672,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:09:00','2024-05-24 15:09:00','3720934e-2dcc-4899-a756-cd34f9d67b30'),(12673,12673,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:00','2024-05-24 15:09:00','695858fb-d467-4cf5-a900-162661295312'),(12674,12674,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 15:09:00','2024-05-24 15:09:00','e5c76b2e-492e-40b4-8b2d-0b9718523dd2'),(12675,12675,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:08','2024-05-24 15:09:08','42803cf7-a721-438b-afc3-56137ad42066'),(12676,12676,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:09:08','2024-05-24 15:09:08','99adb6b9-2a17-42cb-994f-852f2de9b3b0'),(12677,12677,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:08','2024-05-24 15:09:08','f5ad4419-2b86-4ef6-aa2a-e0ceeb802967'),(12678,12678,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:09:08','2024-05-24 15:09:08','f0de6fad-b3eb-48fc-ac80-8a13b486402f'),(12679,12679,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:08','2024-05-24 15:09:08','c923f77d-a279-4d12-9141-c39346448b4f'),(12680,12680,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\"}',1,'2024-05-24 15:09:08','2024-05-24 15:09:08','54ca8cf1-a1a8-461e-90d4-f4fa4e1f1f16'),(12681,12681,1,'CDC; Arkansas Department of Health','cdc-arkansas-department-of-health','resource-sources/cdc-arkansas-department-of-health',NULL,1,'2024-05-24 15:09:13','2024-05-24 15:09:44','81ec9d8b-b9e7-4486-bde5-18effaacdc33'),(12682,12682,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:28','2024-05-24 15:09:28','b9d88850-bc34-4581-9421-7daa8ed64145'),(12683,12683,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:09:28','2024-05-24 15:09:28','f3e405fe-f1d4-46c1-8ce3-a30defa5272a'),(12684,12684,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:28','2024-05-24 15:09:28','e92c000d-f850-43e4-856e-0ad4e54ffd51'),(12685,12685,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:09:29','2024-05-24 15:09:29','d37763bf-9ce2-4490-abd1-63eaedaa2174'),(12686,12686,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:29','2024-05-24 15:09:29','bffce254-c594-49c4-9438-2624f0306694'),(12687,12687,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\"}',1,'2024-05-24 15:09:29','2024-05-24 15:09:29','7e5d16a4-a0c9-4c9f-aeca-e8f356b27162'),(12688,12688,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:36','2024-05-24 15:09:36','e10adf17-8a3a-47ac-8516-158639b311c7'),(12689,12689,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:09:36','2024-05-24 15:09:36','e11b0ecf-d0ba-449b-8c20-efca4907ea14'),(12690,12690,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:36','2024-05-24 15:09:36','621752b4-71bb-4824-b57e-66719925e80c'),(12691,12691,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:09:36','2024-05-24 15:09:36','ba291b48-7af0-4e62-a4ee-60c9770ea725'),(12692,12692,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:36','2024-05-24 15:09:36','202102af-68a6-4945-bac0-6aea1cc9ee48'),(12693,12693,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\"}',1,'2024-05-24 15:09:36','2024-05-24 15:09:36','0ee47d87-a075-4325-a928-1d1b64cbf3b3'),(12694,12694,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:40','2024-05-24 15:09:40','291d0d83-3c3f-46e7-84b6-ec1bfcece1eb'),(12695,12695,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:09:40','2024-05-24 15:09:40','e9751c7d-537d-4437-98ad-b51ff8bdc863'),(12696,12696,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:40','2024-05-24 15:09:40','4639d0c3-3e8a-4a32-9231-d566bd993cb3'),(12697,12697,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:09:40','2024-05-24 15:09:40','54079740-447a-49db-aff8-2651099eb381'),(12698,12698,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:40','2024-05-24 15:09:40','d04f0968-f3a3-43c3-96b3-d3b09aeff603'),(12699,12699,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\"}',1,'2024-05-24 15:09:40','2024-05-24 15:09:40','49d28749-27b7-4129-9a9e-d03f66bb7751'),(12700,12700,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:48','2024-05-24 15:09:48','0fbe06b1-2c20-4a14-9cf1-7652ae87d9f7'),(12701,12701,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:09:48','2024-05-24 15:09:48','9a173a04-0c21-4f2f-aa82-9ec0df08c1fa'),(12702,12702,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:48','2024-05-24 15:09:48','ecc8dcc6-f6e1-461f-bffa-52463c9e15f0'),(12703,12703,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:09:48','2024-05-24 15:09:48','a2904ab1-cf98-484f-8b7d-31dea6e96cbd'),(12704,12704,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:48','2024-05-24 15:09:48','4fcacad6-376e-4bc1-9041-1b13bae172ad'),(12705,12705,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\"}',1,'2024-05-24 15:09:48','2024-05-24 15:09:48','1a0f33fa-4d20-4aca-b5cc-b3485ce58fc0'),(12706,12706,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:49','2024-05-24 15:09:49','aee91460-213d-4854-a39f-2c162a8d7f97'),(12707,12707,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:09:49','2024-05-24 15:09:49','489c8ad7-3ea9-4230-82bf-524e781c152d'),(12708,12708,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:49','2024-05-24 15:09:49','2fdd7b56-7b8a-4e70-a4df-8367617fcaf5'),(12709,12709,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:09:49','2024-05-24 15:09:49','7f06ce6b-0e86-4a69-8b5b-9e5ebd6bc737'),(12710,12710,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:49','2024-05-24 15:09:49','9476cb27-5486-49d5-96aa-b8df528af632'),(12711,12711,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:09:49','2024-05-24 15:09:49','be9d7360-a79f-4fae-858d-fceb768db76f'),(12712,12712,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:50','2024-05-24 15:09:50','7767498c-c7c1-4132-9db7-a8a85d8da1a7'),(12713,12713,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:09:50','2024-05-24 15:09:50','c5cca672-7ef5-4c67-a399-07170ed5dca0'),(12714,12714,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:50','2024-05-24 15:09:50','fc587e7a-682e-4baa-a2ed-6523d26f0976'),(12715,12715,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:09:50','2024-05-24 15:09:50','d3297aba-53b3-4251-8b04-883f56fe3143'),(12716,12716,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:50','2024-05-24 15:09:50','06895ea6-e81a-4fe5-b33a-83d17371a99a'),(12717,12717,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:09:50','2024-05-24 15:09:50','2ef5f99a-cf69-45be-87ae-e37aa1694456'),(12718,12718,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:09:50','2024-05-24 15:09:50','b2842ee8-b4a1-492a-8eac-510f6f85be93'),(12719,12719,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 15:09:51','2024-05-24 15:09:51','95fc4dad-c066-45b6-a12e-b14321d765f5'),(12720,12720,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:02','2024-05-24 15:10:02','5287ba5a-43ba-4050-8ee0-75530d5f064e'),(12721,12721,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:10:02','2024-05-24 15:10:02','06b437fe-bb06-4b59-9868-839228830c3b'),(12722,12722,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:02','2024-05-24 15:10:02','c89fa095-87cf-4bf5-8070-8fe433437dc0'),(12723,12723,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:10:02','2024-05-24 15:10:02','ba54e5eb-c14e-4d07-9c88-c1eb98b35bc6'),(12724,12724,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:02','2024-05-24 15:10:02','dbed2058-3d62-4a0e-83e5-086e05c96dfd'),(12725,12725,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:10:02','2024-05-24 15:10:02','392a155b-12a7-45ea-9185-93fd453df5cf'),(12726,12726,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:02','2024-05-24 15:10:02','bf7c94f4-e1a5-41b0-a139-7455c3040a82'),(12727,12727,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\"}',1,'2024-05-24 15:10:02','2024-05-24 15:10:02','4394657c-ad9f-42d5-a6a8-41106a7ba333'),(12728,12728,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:09','2024-05-24 15:10:09','4d7be72b-3097-4234-b1ff-82509824a924'),(12729,12729,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:10:10','2024-05-24 15:10:10','a8c941cf-b748-4005-9a41-2e9cb7c011b7'),(12730,12730,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:10','2024-05-24 15:10:10','9c2ea5c5-3d53-4db4-bbbc-32e25ecc43dd'),(12731,12731,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:10:10','2024-05-24 15:10:10','fcf6526d-1812-4047-ba72-b2621d662ef1'),(12732,12732,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:10','2024-05-24 15:10:10','de786ba8-0f03-416c-a1a4-b5e56c29b82b'),(12733,12733,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:10:10','2024-05-24 15:10:10','0b12bdf3-a77b-4317-bb4e-b9aaa3925216'),(12734,12734,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:10','2024-05-24 15:10:10','e0cad102-7b88-473e-bfb9-4d5880ca94a4'),(12735,12735,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\"}',1,'2024-05-24 15:10:10','2024-05-24 15:10:10','7ead872c-4606-4fd6-b70f-31ce74dffd06'),(12736,12736,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:17','2024-05-24 15:10:17','5d629bfd-2d73-4c14-8a8a-6a74ae365867'),(12737,12737,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:10:17','2024-05-24 15:10:17','ce1f5cfa-3320-4de2-838c-1c740340ee6a'),(12738,12738,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:17','2024-05-24 15:10:17','ea6f7748-59e5-42d6-bb55-b344190177c2'),(12739,12739,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:10:17','2024-05-24 15:10:17','0389b394-0469-4189-a2fa-40dc8801c75c'),(12740,12740,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:17','2024-05-24 15:10:17','00906500-caff-40a3-8177-7763cef5a873'),(12741,12741,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:10:17','2024-05-24 15:10:17','7d8bbc86-ba9a-4aab-9b92-940400de5a9f'),(12742,12742,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:17','2024-05-24 15:10:17','35f7081e-79fa-450a-9b70-e3e326b223a4'),(12743,12743,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ajicjournal.org/article/S0196-6553(22)00544-2/abstract\"}',1,'2024-05-24 15:10:17','2024-05-24 15:10:17','ed55a90d-47ab-45de-ab1d-53cd69c48b82'),(12744,12744,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:22','2024-05-24 15:10:22','3590c166-91b8-4bd8-a8cd-e82606c938e7'),(12745,12745,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:10:22','2024-05-24 15:10:22','2c8cfe76-25ed-42f9-98fc-dea20ca800ef'),(12746,12746,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:22','2024-05-24 15:10:22','5cc08c25-1c72-4c45-a608-b6bc2f754237'),(12747,12747,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:10:22','2024-05-24 15:10:22','a833993e-d50b-4b2c-b28b-15aaca953e25'),(12748,12748,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:22','2024-05-24 15:10:22','23bd415b-7d06-49e4-a43c-b889f69dee49'),(12749,12749,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:10:22','2024-05-24 15:10:22','68789d20-fcad-46d7-8c01-7a10f2c9ca37'),(12750,12750,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:22','2024-05-24 15:10:22','2aaaf285-c07b-4f0c-a4dd-13faa8678d94'),(12751,12751,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ajicjournal.org/article/S0196-6553(22)00544-2/abstract\"}',1,'2024-05-24 15:10:22','2024-05-24 15:10:22','93c512e7-1e8e-4aab-b841-e9c9c0085668'),(12752,12752,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:24','2024-05-24 15:10:24','d59867f9-4333-451d-9854-d25fa0ef3f87'),(12753,12753,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:10:24','2024-05-24 15:10:24','0fa6b373-1105-4dfe-b215-83cfa01d21d1'),(12754,12754,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:24','2024-05-24 15:10:24','9768c5d8-4df3-40a3-964d-cf2ae3cf878a'),(12755,12755,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:10:24','2024-05-24 15:10:24','ee038535-e9c8-4527-8e21-df438a87b0a1'),(12756,12756,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:24','2024-05-24 15:10:24','455b1076-3614-4c3e-802b-6e79f1d82bd5'),(12757,12757,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:10:24','2024-05-24 15:10:24','e97f3c59-900d-4cc7-9bba-11cd931dcc21'),(12758,12758,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:24','2024-05-24 15:10:24','294d9e5b-5512-4193-97dd-a8a6c6aec0df'),(12759,12759,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ajicjournal.org/article/S0196-6553(22)00544-2/abstract\"}',1,'2024-05-24 15:10:24','2024-05-24 15:10:24','e6819782-1086-4578-9ecd-39efec90eab1'),(12760,12760,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:30','2024-05-24 15:10:30','a2100b92-a28f-49f2-8d18-161fad990499'),(12761,12761,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:10:30','2024-05-24 15:10:30','2508588f-55d6-454b-b205-6bda3e86d434'),(12762,12762,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:30','2024-05-24 15:10:30','36a906de-0222-4591-b187-6e2d66ea3b49'),(12763,12763,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:10:30','2024-05-24 15:10:30','b3092389-6de5-4fff-9fd0-fa461ba34388'),(12764,12764,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:30','2024-05-24 15:10:30','030db5d0-982a-4692-b527-0d7cd9e534db'),(12765,12765,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:10:30','2024-05-24 15:10:30','db75eb80-2d02-46e7-8679-9b463ec0fe76'),(12766,12766,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:30','2024-05-24 15:10:30','83ff7845-158d-42d9-8a34-d8d483a5b91d'),(12767,12767,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ajicjournal.org/article/S0196-6553(22)00544-2/abstract\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article includes checklists for assessing facility linen management practices.\"}',1,'2024-05-24 15:10:30','2024-05-24 15:10:30','3ab9b890-dea2-42e4-8157-d6fcfb03963c'),(12768,12768,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:32','2024-05-24 15:10:32','89380583-28c6-46f3-919f-7a9443a4bc34'),(12769,12769,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:10:32','2024-05-24 15:10:32','fd725aa2-ba97-4e14-8eec-5c2fb4732b57'),(12770,12770,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:32','2024-05-24 15:10:32','1bf74aa0-0dea-4bcd-bc00-33c16ae73e86'),(12771,12771,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:10:32','2024-05-24 15:10:32','7a4d7b20-daca-4688-a85f-dae4f5a497c5'),(12772,12772,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:32','2024-05-24 15:10:32','083ac864-b6c7-411d-8fa8-75be45d484fd'),(12773,12773,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:10:32','2024-05-24 15:10:32','d5c3b647-fa19-4cc4-8916-17866d4be062'),(12774,12774,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:32','2024-05-24 15:10:32','d7ed5f53-ede1-43ab-80ec-bb6c3c0bd607'),(12775,12775,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ajicjournal.org/article/S0196-6553(22)00544-2/abstract\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article includes checklists for assessing facility linen management practices.\"}',1,'2024-05-24 15:10:32','2024-05-24 15:10:32','70ea3d6e-4b5f-47a4-82ff-785f6671f4a1'),(12776,12776,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:32','2024-05-24 15:10:32','55ce215e-9ca4-43cb-8e39-fe65e61668b6'),(12777,12777,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 15:10:32','2024-05-24 15:10:32','e8757221-1ce6-427a-b876-d2e46ba2b8dd'),(12778,12778,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:42','2024-05-24 15:10:42','626c673b-deae-4045-a1a3-508e4d978d86'),(12779,12779,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:10:42','2024-05-24 15:10:42','08d792b4-896d-4ba8-9bfc-d9ea19332311'),(12780,12780,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:42','2024-05-24 15:10:42','c151b23f-cfb1-4aa5-a6f3-70aa5139f8c4'),(12781,12781,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:10:42','2024-05-24 15:10:42','2702e1ad-c5f1-4220-a0ae-80236c9de9db'),(12782,12782,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:42','2024-05-24 15:10:42','28f0fca8-171c-4072-92a2-45083bb609fa'),(12783,12783,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:10:42','2024-05-24 15:10:42','495dc831-5651-420d-9c60-6fc8ff4401ea'),(12784,12784,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:42','2024-05-24 15:10:42','385059f7-8d4e-44a7-a5d6-8bcec45838a4'),(12785,12785,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ajicjournal.org/article/S0196-6553(22)00544-2/abstract\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article includes checklists for assessing facility linen management practices.\"}',1,'2024-05-24 15:10:42','2024-05-24 15:10:42','756822fc-74e3-44a1-b83c-6e772e21d75c'),(12786,12786,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:42','2024-05-24 15:10:42','85cc7764-725f-4865-9fd3-1dbe4666207c'),(12787,12787,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Candida auris Resources\"}',1,'2024-05-24 15:10:42','2024-05-24 15:10:42','5d93e71a-9900-4468-9515-215a7789ddf6'),(12788,12788,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:52','2024-05-24 15:10:52','8bac941c-85c4-4e88-93b1-75fc0336c565'),(12789,12789,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"https://www.cdc.gov/fungal/php/guidance-investigating-outbreaks/index.html\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\"}',1,'2024-05-24 15:10:52','2024-05-24 15:10:52','a22bac0e-8acf-4b9f-8986-838002c04c2b'),(12790,12790,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:52','2024-05-24 15:10:52','99067f85-3374-4e02-bf1b-9de48b017bd0'),(12791,12791,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\"}',1,'2024-05-24 15:10:52','2024-05-24 15:10:52','2c59037f-c2d8-441b-8cb9-94554c74da8c'),(12792,12792,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:52','2024-05-24 15:10:52','47866ed8-9aa8-4ca7-bc93-0066e2362ad9'),(12793,12793,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\"}',1,'2024-05-24 15:10:52','2024-05-24 15:10:52','babc07fa-5331-42b1-b9ef-4abf58f8feb4'),(12794,12794,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:52','2024-05-24 15:10:52','3bb29fa1-f5e4-4109-bdc7-cfd668ea3a79'),(12795,12795,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health; Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ajicjournal.org/article/S0196-6553(22)00544-2/abstract\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article includes checklists for assessing facility linen management practices.\"}',1,'2024-05-24 15:10:52','2024-05-24 15:10:52','5765b379-da71-48dd-bd96-f02e61f999b2'),(12796,12796,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:10:52','2024-05-24 15:10:52','39e45ecb-9721-4bab-976c-600c34d643f5'),(12797,12797,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Candida auris Resources\"}',1,'2024-05-24 15:10:52','2024-05-24 15:10:52','b668bf38-7ce2-41a3-8e21-da56f36670c9'),(12798,12798,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:13:03','2024-05-24 15:13:03','be0ef503-6bfb-40b7-9648-9ebab97f7816'),(12799,12799,1,NULL,'__temp_vllypelwfmfaxfldxknoedbtsnnhwfgkqgyb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/fungal/outbreaks/files/mold-outbreaks-line-list.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This sample line list can be used in the investigation of healthcare-associated mold outbreaks. This will show up in your downloads folder.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 15:13:03','2024-07-30 17:49:17','991b4765-c685-4f3c-8022-e64931f37864'),(12800,12800,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:13:03','2024-05-24 15:13:03','fcfc9dc5-d623-4bde-b183-8c2957867117'),(12801,12801,1,NULL,'__temp_jcisbucfobtbrsxklslksuunzubpgusvdqya',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Patient Notification About Suspected Hospital-Associated Outbreaks of Invasive Mold Infections: Considerations for Public Health and Hospital Personnel\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://pubmed.ncbi.nlm.nih.gov/34109919/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article addresses the intricacies and challenges of making patient notifications in the context of hospital-associated clusters of invasive mold infections, with recommended practices.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 15:13:03','2024-06-13 13:51:37','6d4f0d03-760f-47f2-804a-b378bf07889f'),(12802,12802,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:13:03','2024-05-24 15:13:03','2ff1f59d-6ead-42fd-ada9-c7dd73b3f892'),(12803,12803,1,NULL,'__temp_krspgaevhxcbtrwskmjnfkiepjjzhbausbzf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital - Arkansas, June 2019 - May 2021\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://academic.oup.com/ofid/article/9/10/ofac510/6761764\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article describes a large outbreak of healthcare-associated mucormycosis that was potentially linked to linens.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 15:13:03','2024-06-13 13:51:37','fd822a28-05dd-4532-826e-d78d5bccae51'),(12804,12804,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:13:03','2024-05-24 15:13:03','2eb291bf-909e-4baf-afa8-2bcbd1205267'),(12805,12805,1,NULL,'__temp_nmrwhqzbygmponhgvsqhirauxxuehqweukil',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Keeping Health Care Linens Clean: Underrecognized Hazards and Critical Control Points to Avoid Contamination of Laundered Health Care Textiles\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ajicjournal.org/article/S0196-6553(22)00544-2/abstract\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article includes checklists for assessing facility linen management practices.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 15:13:03','2024-06-13 13:51:37','1ba57e86-15aa-4222-bacd-e253b444cbd7'),(12806,12806,1,NULL,NULL,NULL,NULL,1,'2024-05-24 15:15:15','2024-05-24 15:15:15','1395a489-7b61-4bc5-85a8-84200f605b93'),(12807,12807,1,'COVID-19','covid-19','diseases-pathogens/covid-19',NULL,1,'2024-05-24 16:37:07','2024-05-24 16:37:58','609376ea-791c-4f9e-86f9-2423bb5754fe'),(12808,12808,1,NULL,'__temp_bcvyioaejkuuyhtahhowpdlzcyemhcukeojp',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called SARS-CoV-2 infection</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19\"}',1,'2024-05-24 16:37:58','2024-06-10 20:54:05','659f8235-43e5-4a86-819d-6a338d03135f'),(12809,12809,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 16:37:58','2024-06-03 20:18:48','2626d40c-edf6-4eea-a4ea-6a8a70c7ca80'),(12810,12810,1,'23311 lores',NULL,NULL,NULL,1,'2024-05-24 16:39:23','2024-05-24 16:39:23','b434d890-f5c9-4cb0-a10c-67efefe99e32'),(12811,12811,1,'COVID-19','covid-19','diseases-pathogens/covid-19',NULL,1,'2024-05-24 16:39:43','2024-05-24 16:39:43','0d4f1873-9f59-445c-bb19-684a3d68ec77'),(12812,12812,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Coronavirus Disease (COVID-19) is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and was first identified in December 2019. Transmission of SARS-CoV-2 in healthcare settings is a recognized risk that can manifest in the form of outbreaks and requires careful attention to infection control procedures.</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Also called SARS-CoV-2 infection\"}',1,'2024-05-24 16:39:43','2024-05-24 16:39:43','f451560d-14b3-4ca4-9c45-1f3604b25f2e'),(12813,12813,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 16:39:43','2024-05-24 16:39:43','dbf8a83d-7719-4349-a59f-3df7a449fdf1'),(12964,12964,1,'CTSE','ctse','resource-sources/ctse',NULL,1,'2024-05-24 16:44:23','2024-05-24 16:54:34','3c6071af-4d32-4804-9ad9-bca5683595be'),(13147,13147,1,'Definitions','definitions','topic-tags/definitions',NULL,1,'2024-05-24 16:45:55','2024-05-24 16:54:34','b66f252e-3cbe-4246-998c-ace73eda98c0'),(13178,13178,1,'Reporting Thresholds','reporting-thresholds','topic-tags/reporting-thresholds',NULL,1,'2024-05-24 16:46:11','2024-05-24 16:54:34','70a80834-4236-4b26-80bb-b82e07156565'),(13459,13459,1,'Guidance','guidance','topic-tags/guidance',NULL,1,'2024-05-24 16:48:17','2024-05-24 16:54:35','20f56324-9cd4-46dd-913e-9110bd6fc4e8'),(13680,13680,1,'Toolkit','toolkit','topic-tags/toolkit',NULL,1,'2024-05-24 16:49:47','2024-05-24 16:54:35','0faae88b-b546-4903-ac8e-75bd182c4b9d'),(13725,13725,1,'Nursing Homes','nursing-homes','topic-tags/nursing-homes',NULL,1,'2024-05-24 16:50:10','2024-05-24 16:54:35','bff83aaa-f90f-4970-b13f-cd9e63ce10f1'),(13736,13736,1,'Long-Term Care Facilities','long-term-care-facilities','topic-tags/long-term-care-facilities',NULL,1,'2024-05-24 16:50:17','2024-05-24 16:54:35','241074ce-a635-4e66-88e3-257e3fa0fc4d'),(13975,13975,1,'Recommendations','recommenda','topic-tags/recommenda',NULL,1,'2024-05-24 16:51:42','2024-05-24 16:54:35','61f3682d-6669-4a75-b081-4d7d908c01ad'),(14128,14128,1,'Hospital','hospital','topic-tags/hospital',NULL,1,'2024-05-24 16:52:28','2024-05-24 16:54:35','9b7c8fe5-0eca-482b-a37c-70aeb1c9f458'),(14135,14135,1,'Dialysis Facility','dialysis-facility','topic-tags/dialysis-facility',NULL,1,'2024-05-24 16:52:32','2024-05-24 16:54:35','b104d5cc-7274-41ee-9c7d-0f1effeda73a'),(14316,14316,1,'Module','module','topic-tags/module',NULL,1,'2024-05-24 16:54:08','2024-05-24 16:54:35','c1bb9bfd-66eb-43f8-bc1b-cddc970a983c'),(14329,14329,1,'Dashboard','dashboard','topic-tags/dashboard',NULL,1,'2024-05-24 16:54:15','2024-05-24 16:54:35','b1075b51-20a0-42a7-a7d0-73a5841b2b3d'),(14374,14374,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:32','2024-05-24 16:54:32','a7400795-cd18-4e65-8c8a-a80f76ae382a'),(14375,14375,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Coronavirus Disease (COVID-19) is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and was first identified in December 2019. Transmission of SARS-CoV-2 in healthcare settings is a recognized risk that can manifest in the form of outbreaks and requires careful attention to infection control procedures.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About COVID-19\"}',1,'2024-05-24 16:54:32','2024-05-24 16:54:32','774855bc-439e-4a66-aed0-de91e0b81868'),(14376,14376,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:32','2024-05-24 16:54:32','04ab98bc-d151-4315-9839-dcbd0abb73b4'),(14377,14377,1,NULL,'__temp_qjcqyooemaxqjsihxhgtmayekgbhjefspdea',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/wp-content/uploads/2024/01/COVID-19-HC-Outbreak-Definition-Guidance_January-2024.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"These proposed investigation/reporting thresholds and outbreak definitions are provided to support the early detection of possible outbreaks and timely intervention to prevent transmission.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 16:54:32','2024-06-13 13:50:13','49d4838b-55cc-461a-90f3-c123bed77b04'),(14378,14378,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:32','2024-05-24 16:54:32','122ea847-3502-45aa-9add-46f824c35382'),(14379,14379,1,NULL,'__temp_arjjquljsgcwzmvrzpqzbskknongblwhmpwv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/viral-respiratory-prevention/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/viral/prevent-viral.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource, published at the start of the 2023-2024 respiratory virus season, provides guidance for preventing all viral respiratory pathogens,  including influenza virus and SARS-CoV-2 infection, in healthcare settings.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 16:54:32','2024-06-13 13:50:13','b403a7c9-4594-449d-a81a-477721a3f86b'),(14380,14380,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:32','2024-05-24 16:54:32','c535ab29-babd-4650-8fce-c63718904770'),(14381,14381,1,NULL,'__temp_kvdsprjundflhtsgcqzqkobdveghrwtaiwci',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Respiratory Pathogens Toolkit\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/respiratory-virus-toolkit/?CDC_AAref_Val=https://www.cdc.gov/longtermcare/prevention/viral-respiratory-toolkit.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit was published at the start of the 2023-2024 respiratory virus season, alongside general healthcare setting guidance, and serves as a setting-specific resource for nursing homes and long-term care facilities.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 16:54:32','2024-07-29 19:29:53','4d58dbb1-299f-4786-948a-fd75ba27558c'),(14382,14382,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:32','2024-05-24 16:54:32','28c5cc04-71f9-4a58-9703-214d20b18937'),(14383,14383,1,NULL,'__temp_lmmacgglecopwpdkamthpsqhkxqyjzzdxvtv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency. This guidance provides a framework for facilities to implement select infection prevention and control practices based on their individual circumstances.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 16:54:32','2024-06-13 13:50:13','d4c84198-d81b-40b8-ace0-1bc2c946f429'),(14384,14384,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:32','2024-05-24 16:54:32','951c63db-cf4c-4708-a928-a57ef5c7ee2a'),(14385,14385,1,NULL,'__temp_yxfbxmfnhnihvcpznrwastguhswwmwauqvss',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"National Healthcare Safety Network (NHSN): COVID-19 Modules and Dashboards\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/nhsn/covid19/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes NHSN COVID-19 reference materials relevant to hospital, long-term care facility, and dialysis facility personnel.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 16:54:32','2024-06-13 13:50:13','d01ec231-e8d7-43bf-8903-10a23c8d2909'),(14386,14386,1,'COVID-19','covid-19','diseases-pathogens/covid-19',NULL,1,'2024-05-24 16:54:32','2024-05-24 16:54:32','5ed73a47-4446-4feb-b563-4cbe1ca62664'),(14387,14387,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called SARS-CoV-2 infection</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19 Resources\"}',1,'2024-05-24 16:54:32','2024-05-24 16:54:32','9b0eacd7-7df6-4f18-a9fa-3fe53b1cf255'),(14388,14388,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:32','2024-05-24 16:54:32','77143e89-fffb-4e01-b4e2-6dfe506e6068'),(14389,14389,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Coronavirus Disease (COVID-19) is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and was first identified in December 2019. Transmission of SARS-CoV-2 in healthcare settings is a recognized risk that can manifest in the form of outbreaks and requires careful attention to infection control procedures.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About COVID-19\"}',1,'2024-05-24 16:54:32','2024-05-24 16:54:32','35728259-1300-41f1-aac1-2e80c8bb123b'),(14390,14390,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:33','2024-05-24 16:54:33','c621d926-2d9e-4054-8bcb-68ddc917c9bf'),(14391,14391,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/wp-content/uploads/2024/01/COVID-19-HC-Outbreak-Definition-Guidance_January-2024.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"These proposed investigation/reporting thresholds and outbreak definitions are provided to support the early detection of possible outbreaks and timely intervention to prevent transmission.\"}',1,'2024-05-24 16:54:33','2024-05-24 16:54:33','3bd4f495-993a-46c6-bf69-c85ee53ce84d'),(14392,14392,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:33','2024-05-24 16:54:33','b46a0968-fc17-441a-8b37-a1b0cb1168eb'),(14393,14393,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/viral-respiratory-prevention/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/viral/prevent-viral.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource, published at the start of the 2023-2024 respiratory virus season, provides guidance for preventing all viral respiratory pathogens,  including influenza virus and SARS-CoV-2 infection, in healthcare settings.\"}',1,'2024-05-24 16:54:33','2024-05-24 16:54:33','d35c2ba5-1aff-4ab0-bff7-6533e9fca10b'),(14394,14394,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:33','2024-05-24 16:54:33','ad0e0390-ddf6-413a-9ff5-04ff14f77c02'),(14395,14395,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Respiratory Pathogens Toolkit\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/respiratory-virus-toolkit/?CDC_AAref_Val=https://www.cdc.gov/longtermcare/prevention/viral-respiratory-toolkit.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit was published at the start of the 2023-2024 respiratory virus season, alongside general healthcare setting guidance, and serves as a setting-specific resource for nursing homes and long-term care facilities.\"}',1,'2024-05-24 16:54:33','2024-05-24 16:54:33','4c833a05-49bf-4849-87a0-b2db7b477169'),(14396,14396,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:33','2024-05-24 16:54:33','76992deb-30a3-489d-9586-5d2144f1d7b7'),(14397,14397,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency. This guidance provides a framework for facilities to implement select infection prevention and control practices based on their individual circumstances.\"}',1,'2024-05-24 16:54:33','2024-05-24 16:54:33','61bf6f19-77bc-4ff6-8d3d-7ab42be8d849'),(14398,14398,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:54:33','2024-05-24 16:54:33','813cda77-ad8f-481c-9881-1d80df905606'),(14399,14399,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"National Healthcare Safety Network (NHSN): COVID-19 Modules and Dashboards\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/nhsn/covid19/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes NHSN COVID-19 reference materials relevant to hospital, long-term care facility, and dialysis facility personnel.\"}',1,'2024-05-24 16:54:33','2024-05-24 16:54:33','3deccff0-75ab-4fa7-99c5-74975c422b47'),(14400,14400,1,'COVID-19 Header',NULL,NULL,NULL,1,'2024-05-24 16:55:27','2024-05-24 16:55:27','63789706-c7a9-4272-afca-351d24e667b2'),(14413,14413,1,'COVID-19','covid-19','diseases-pathogens/covid-19',NULL,1,'2024-05-24 16:58:29','2024-05-24 16:58:29','6a30aa2d-f296-4d38-a85b-74c583f8388f'),(14414,14414,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called SARS-CoV-2 infection</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19 Resources\"}',1,'2024-05-24 16:58:29','2024-05-24 16:58:29','fec8291e-d73f-4ce3-80eb-1c9e5255ad80'),(14415,14415,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:58:29','2024-05-24 16:58:29','ec18d4d0-1dcb-430e-b2f8-a9655cd541db'),(14416,14416,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/wp-content/uploads/2024/01/COVID-19-HC-Outbreak-Definition-Guidance_January-2024.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"These proposed investigation/reporting thresholds and outbreak definitions are provided to support the early detection of possible outbreaks and timely intervention to prevent transmission.\"}',1,'2024-05-24 16:58:29','2024-05-24 16:58:29','31e7868c-cbb5-4328-88e5-a5ff1c61622d'),(14417,14417,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:58:29','2024-05-24 16:58:29','d41ba5c0-8e02-47a7-a2b6-56e64e682288'),(14418,14418,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/viral-respiratory-prevention/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/viral/prevent-viral.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource, published at the start of the 2023-2024 respiratory virus season, provides guidance for preventing all viral respiratory pathogens,  including influenza virus and SARS-CoV-2 infection, in healthcare settings.\"}',1,'2024-05-24 16:58:29','2024-05-24 16:58:29','47a70eb7-8169-407f-94c8-70e98581c382'),(14419,14419,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:58:29','2024-05-24 16:58:29','a5cceb99-fc3b-4325-9812-ddfce5aa2bcb'),(14420,14420,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Respiratory Pathogens Toolkit\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/respiratory-virus-toolkit/?CDC_AAref_Val=https://www.cdc.gov/longtermcare/prevention/viral-respiratory-toolkit.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit was published at the start of the 2023-2024 respiratory virus season, alongside general healthcare setting guidance, and serves as a setting-specific resource for nursing homes and long-term care facilities.\"}',1,'2024-05-24 16:58:29','2024-05-24 16:58:29','cd5f8e4e-42d6-4794-af9a-28c0ae11136d'),(14421,14421,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:58:29','2024-05-24 16:58:29','47460429-4355-45b7-9954-97a3086a4e48'),(14422,14422,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency. This guidance provides a framework for facilities to implement select infection prevention and control practices based on their individual circumstances.\"}',1,'2024-05-24 16:58:29','2024-05-24 16:58:29','58566e4d-7e07-43de-85a1-3728fe3545fb'),(14423,14423,1,NULL,NULL,NULL,NULL,1,'2024-05-24 16:58:29','2024-05-24 16:58:29','6f33f943-0cb6-4b6a-a73d-f1c34b60f041'),(14424,14424,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"National Healthcare Safety Network (NHSN): COVID-19 Modules and Dashboards\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/nhsn/covid19/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes NHSN COVID-19 reference materials relevant to hospital, long-term care facility, and dialysis facility personnel.\"}',1,'2024-05-24 16:58:29','2024-05-24 16:58:29','d241ae42-bad0-4176-be72-c43b8d98c1ec'),(14425,14425,1,'COVID-19','covid-19','diseases-pathogens/covid-19',NULL,1,'2024-05-24 17:26:42','2024-05-24 17:26:42','3fd747b5-3289-484f-a04d-e87618dabad8'),(14426,14426,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:26:42','2024-05-24 17:26:42','19039b46-f0c0-4a35-a9e2-f09586167b00'),(14427,14427,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/wp-content/uploads/2024/01/COVID-19-HC-Outbreak-Definition-Guidance_January-2024.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"These proposed investigation/reporting thresholds and outbreak definitions are provided to support the early detection of possible outbreaks and timely intervention to prevent transmission.\"}',1,'2024-05-24 17:26:42','2024-05-24 17:26:42','fa3fd6e5-d2b3-409e-b4b4-eddd6a2969cb'),(14428,14428,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:26:42','2024-05-24 17:26:42','c59e0736-f572-4a82-bbf4-a4beea9a5b7d'),(14429,14429,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/viral-respiratory-prevention/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/viral/prevent-viral.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource, published at the start of the 2023-2024 respiratory virus season, provides guidance for preventing all viral respiratory pathogens,  including influenza virus and SARS-CoV-2 infection, in healthcare settings.\"}',1,'2024-05-24 17:26:42','2024-05-24 17:26:42','2e95e00a-ccb5-4fc7-8eb8-58f3cdfda772'),(14430,14430,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:26:42','2024-05-24 17:26:42','0ffd5282-b2fb-45da-bd9f-9f109de27a86'),(14431,14431,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Respiratory Pathogens Toolkit\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/respiratory-virus-toolkit/?CDC_AAref_Val=https://www.cdc.gov/longtermcare/prevention/viral-respiratory-toolkit.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit was published at the start of the 2023-2024 respiratory virus season, alongside general healthcare setting guidance, and serves as a setting-specific resource for nursing homes and long-term care facilities.\"}',1,'2024-05-24 17:26:42','2024-05-24 17:26:42','53dde545-9904-4dbc-a780-a84a00336683'),(14432,14432,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:26:42','2024-05-24 17:26:42','db24b687-aceb-4499-89ae-4bf578500b51'),(14433,14433,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency. This guidance provides a framework for facilities to implement select infection prevention and control practices based on their individual circumstances.\"}',1,'2024-05-24 17:26:42','2024-05-24 17:26:42','779ef2b7-17e4-487c-a365-7ad52bb3c483'),(14434,14434,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:26:42','2024-05-24 17:26:42','26f20154-149a-41ef-a33c-f1dbcc2771a0'),(14435,14435,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"National Healthcare Safety Network (NHSN): COVID-19 Modules and Dashboards\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/nhsn/covid19/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes NHSN COVID-19 reference materials relevant to hospital, long-term care facility, and dialysis facility personnel.\"}',1,'2024-05-24 17:26:42','2024-05-24 17:26:42','a7639b3e-f4f5-48b1-a9e3-40a48e0e0d67'),(14447,14447,1,'CDC; CSTE','cdc-cste','resource-sources/cdc-cste',NULL,1,'2024-05-24 17:40:55','2024-05-24 17:41:05','9c7fe3c3-e0c1-416b-8ed4-3a7afb80b500'),(14454,14454,1,'Another Variable List','standard-variable-list-2','tools/standard-variable-list-2',NULL,1,'2024-05-24 17:42:18','2024-05-24 17:42:18','23a11ab0-9a5a-4ec8-8eda-791651a6a626'),(14455,14455,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:42:18','2024-05-24 17:42:18','f07fa085-8d15-4045-81e7-9fb027e66bcb'),(14456,14456,1,NULL,NULL,NULL,'{\"be5d4521-3ac1-4910-b517-61f422d78b5f\": \"type2\"}',1,'2024-05-24 17:42:18','2024-05-24 17:42:18','e05418c6-f3a5-4c15-b86c-d26f38d49b04'),(14457,14457,1,NULL,NULL,NULL,'{\"5e69eb2b-d9e6-4bc3-96d9-bd135014dc13\": \"Includes health equity information\", \"8fb44257-6036-45ee-828d-a67768a3ce5d\": \"Decide what information to collect for an HAI outbreak investigation\"}',1,'2024-05-24 17:42:18','2024-05-24 17:42:18','115987ff-f350-4d90-9201-6647c8c65fd9'),(14458,14458,1,NULL,NULL,NULL,'{\"351bcb28-665a-4c36-ac0f-d342fd5624b8\": \"<p><a href=\\\"#\\\">Optional: committee</a></p>\"}',1,'2024-05-24 17:42:18','2024-05-24 17:42:18','fccaf91d-fc1d-439b-9c92-a7fa830063b3'),(14459,14459,1,NULL,NULL,NULL,'{\"25408066-3b85-449b-9ac9-49eef328c2cc\": {\"date\": \"2024-03-29 07:00:00\"}, \"39a47072-9f48-45a8-b431-8d598b6f7978\": {\"date\": \"2024-05-07 07:00:00\"}}',1,'2024-05-24 17:42:18','2024-05-24 17:42:18','8129f154-1a5e-4f06-8f12-65440b70b528'),(14460,14460,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:42:18','2024-05-24 17:42:18','b6d717a3-3b6c-436b-846b-3deab06459dd'),(14461,14461,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:42:18','2024-05-24 17:42:18','dcbce512-dd47-4872-b2de-ab82d8d83eeb'),(14462,14462,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:42:18','2024-05-24 17:42:18','f320de11-62fa-4048-a909-c67316a7f25d'),(14463,14463,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:42:18','2024-05-24 17:42:18','26fd937d-c216-4f4f-bed3-7db90a5c99aa'),(14465,14465,1,'CORHA; CSTE','corha-cste','resource-sources/corha-cste',NULL,1,'2024-05-24 17:43:42','2024-05-24 17:44:40','d2c05fe1-9147-458d-83bf-5cb49ee1ac05'),(14468,14468,1,'Multiple Sources','multiple-sources','resource-sources/multiple-sources',NULL,1,'2024-05-24 17:44:26','2024-05-24 17:44:40','b1fc8efb-e68e-45d2-b48c-80a21a243d10'),(14469,14469,1,'COVID-19','covid-19','diseases-pathogens/covid-19',NULL,1,'2024-05-24 17:44:39','2024-05-24 17:44:39','e3bf9499-3d5a-45cf-a971-47b491045d9d'),(14470,14470,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:44:40','2024-05-24 17:44:40','484933a8-0dab-4efb-86cb-0d252c8e22ca'),(14471,14471,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/wp-content/uploads/2024/01/COVID-19-HC-Outbreak-Definition-Guidance_January-2024.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"These proposed investigation/reporting thresholds and outbreak definitions are provided to support the early detection of possible outbreaks and timely intervention to prevent transmission.\"}',1,'2024-05-24 17:44:40','2024-05-24 17:44:40','901f74bc-da7f-42d1-8357-188e61a15040'),(14472,14472,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:44:40','2024-05-24 17:44:40','9710d7a5-7c52-4faa-9696-0f960071e842'),(14473,14473,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/viral-respiratory-prevention/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/viral/prevent-viral.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource, published at the start of the 2023-2024 respiratory virus season, provides guidance for preventing all viral respiratory pathogens,  including influenza virus and SARS-CoV-2 infection, in healthcare settings.\"}',1,'2024-05-24 17:44:40','2024-05-24 17:44:40','ed049dd1-c920-4280-ad5f-0f113fbfe828'),(14474,14474,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:44:40','2024-05-24 17:44:40','1e9f462c-3900-4118-b0dc-fd8fc46901f1'),(14475,14475,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Respiratory Pathogens Toolkit\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/respiratory-virus-toolkit/?CDC_AAref_Val=https://www.cdc.gov/longtermcare/prevention/viral-respiratory-toolkit.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit was published at the start of the 2023-2024 respiratory virus season, alongside general healthcare setting guidance, and serves as a setting-specific resource for nursing homes and long-term care facilities.\"}',1,'2024-05-24 17:44:40','2024-05-24 17:44:40','09589087-da81-4198-b035-71dd93817c70'),(14476,14476,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:44:40','2024-05-24 17:44:40','306d4923-606f-4bf0-9a3e-b1b282d4bc9e'),(14477,14477,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency. This guidance provides a framework for facilities to implement select infection prevention and control practices based on their individual circumstances.\"}',1,'2024-05-24 17:44:40','2024-05-24 17:44:40','a22f31dd-e2d2-41c9-b799-b2dfe2667bec'),(14478,14478,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:44:40','2024-05-24 17:44:40','317dbb75-4762-4a12-ae2e-6e01145b85f5'),(14479,14479,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"National Healthcare Safety Network (NHSN): COVID-19 Modules and Dashboards\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/nhsn/covid19/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes NHSN COVID-19 reference materials relevant to hospital, long-term care facility, and dialysis facility personnel.\"}',1,'2024-05-24 17:44:40','2024-05-24 17:44:40','d98ba1e8-3b7b-4a39-8c37-b207391a8b94'),(14499,14499,1,'Ebola','ebola','diseases-pathogens/ebola',NULL,1,'2024-05-24 17:47:36','2024-05-24 17:47:36','31efc79b-a357-4409-9ee7-6323539f71e3'),(14500,14500,1,NULL,'__temp_cnarfehtmdbgustzqzqmehavxtfthzwzstrv',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Ebola Virus Disease</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Ebola\"}',1,'2024-05-24 17:47:36','2024-06-13 13:47:55','795ce47c-8364-49d4-920b-d3f2144aefab'),(14501,14501,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 17:47:36','2024-06-03 20:18:48','db3f83b4-e794-4f70-af15-20df443f582d'),(14502,14502,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:36','2024-05-24 17:47:36','5cab99ec-b2c9-4aee-9e08-f09cb2a5bfc0'),(14503,14503,1,NULL,'__temp_paobkymdvtnqfkostrrfvdsqiaqgxcbtsdbm',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health.  The virus can spread person-to-person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Ebola\"}',1,'2024-05-24 17:47:36','2024-07-29 20:02:46','daaa11d5-1144-43a5-8d69-d5f10a2c4b6f'),(14504,14504,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:36','2024-05-24 17:47:36','9e2cb382-74fb-4d54-886b-2896a1e6ea0a'),(14505,14505,1,NULL,'__temp_wtezjdcsyqcefbupgcuxbvvcfesbrrhpdivl',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 17:47:36','2024-06-13 13:47:55','9ccb7d89-f083-44e3-b6d8-15b0ea09e808'),(14506,14506,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:36','2024-05-24 17:47:36','754369d9-1d61-45ac-b3f9-8da51ba10ac4'),(14507,14507,1,NULL,'__temp_agmmcmualdwzdchazbvimtzwwcperxjqcmdf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control Recommendations for U.S. Hospital Patients with Suspected or Confirmed Viral Hemorrhagic Fevers\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/clinicians/evd/infection-control.html\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 17:47:36','2024-06-13 13:47:55','89fc44fa-9029-4ec4-8737-f4b06bd754b1'),(14508,14508,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:36','2024-05-24 17:47:36','fb0108c0-1551-41b9-8b99-57e9accd9516'),(14509,14509,1,NULL,'__temp_hrjaehpqqkzrynczbigvvnzswebaojgpmkvf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s Health Topics Page on Ebola Virus Disease\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-31 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 17:47:36','2024-07-29 20:02:46','966de070-af12-441e-9a02-965068d2debb'),(14510,14510,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:36','2024-05-24 17:47:36','d53cffd6-d67f-4a29-8c41-338c4239e5db'),(14511,14511,1,NULL,'__temp_xtdhqvklvmmavzhfgvzymdbknssyyynzdcdu',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/php/public-health-strategy/vhf-response-planning.html?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 17:47:36','2024-06-13 13:47:55','e028af41-b48a-4b00-a9de-406d4aa71c8c'),(14512,14512,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:36','2024-05-24 17:47:36','d8137326-96bb-42c4-8544-f7e452c1307c'),(14513,14513,1,NULL,'__temp_nkrflbxtxcfbmslhlsdrlxukmvxzdljslenw',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/public-health-gateway/php/communications-resources/health-department-directories.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website provides links to health department websites in all 50 states and the District of Columbia.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 17:47:36','2024-07-29 20:02:46','6f1497f3-ba14-4181-a7d4-1509a473d00a'),(14514,14514,1,'Ebola','ebola','diseases-pathogens/ebola',NULL,1,'2024-05-24 17:47:36','2024-05-24 17:47:36','cfea9574-7e16-4a5e-b71a-42ec504743ab'),(14515,14515,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Ebola Virus Disease</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Ebola\"}',1,'2024-05-24 17:47:36','2024-05-24 17:47:36','4b8cffcb-67f1-4c9f-9a9d-c6a59c2cea81'),(14516,14516,1,NULL,NULL,NULL,'{\"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 17:47:36','2024-05-24 17:47:36','3c0403ec-dd6f-4e48-9848-e94af196ed90'),(14517,14517,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:37','2024-05-24 17:47:37','381631c2-1375-4478-a500-9cbdc29726e0'),(14518,14518,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health.  The virus can spread person-to-person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola Virus Disease\"}',1,'2024-05-24 17:47:37','2024-05-24 17:47:37','03f86267-4a1c-4604-907a-012aa628e603'),(14519,14519,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:37','2024-05-24 17:47:37','11f47c49-1b36-4d9e-9948-c8a40e9d010d'),(14520,14520,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 17:47:37','2024-05-24 17:47:37','20dc16f4-0cc7-402b-887f-5000f67ac5ba'),(14521,14521,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:37','2024-05-24 17:47:37','95f3b3e5-9961-480d-bd2b-03ab71b95d9a'),(14522,14522,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Clinicians, Public Health Professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control Recommendations for U.S. Hospital Patients with Suspected or Confirmed Viral Hemorrhagic Fevers\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/clinicians/evd/infection-control.html\"}',1,'2024-05-24 17:47:37','2024-05-24 17:47:37','59bc9b7b-64e6-4ad0-bbd9-f78dff8bc4dd'),(14523,14523,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:37','2024-05-24 17:47:37','a12fa23f-cfbc-4eb7-a870-dda652adbe93'),(14524,14524,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Clinicians, Public Health Professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 17:47:37','2024-05-24 17:47:37','f732912a-8aea-4d56-b6fb-668aa16601b0'),(14525,14525,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:37','2024-05-24 17:47:37','ca080586-761a-4390-bf28-8c515524e682'),(14526,14526,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health Professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/php/public-health-strategy/vhf-response-planning.html?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 17:47:37','2024-05-24 17:47:37','1ccf611e-fbf7-483c-9f6a-71bf81e772b8'),(14527,14527,1,NULL,NULL,NULL,NULL,1,'2024-05-24 17:47:37','2024-05-24 17:47:37','1213c19e-b1e9-49e6-9ac0-8f47acabc4b9'),(14528,14528,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Clinicians\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/public-health-gateway/php/communications-resources/health-department-directories.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website provides links to health department websites in all 50 states and the District of Columbia\"}',1,'2024-05-24 17:47:37','2024-05-24 17:47:37','8314635c-1ba1-41b4-8bb4-ec20ffd1871e'),(14529,14529,1,'FDA','fda','resource-sources/fda',NULL,1,'2024-05-24 17:48:19','2024-05-24 17:49:42','4b1af9ea-69e4-448f-8a84-c419e3145f9b'),(14914,14914,1,'Journal','journal','resource-sources/journal',NULL,1,'2024-05-24 17:54:20','2024-05-24 17:57:04','e49a7202-295e-4aa8-aa7b-f772b2027ef2'),(15117,15117,1,'California Department of Public Health','california-department-of-public-health','resource-sources/california-department-of-public-health',NULL,1,'2024-05-24 17:55:49','2024-05-24 17:57:04','919780cc-4be8-45b4-946c-5d69e733d9a0'),(15296,15296,1,'Morbidity and Mortality Weekly Report (MMWR)','morbidity-and-mortality-weekly-report-mmwr','resource-sources/morbidity-and-mortality-weekly-report-mmwr',NULL,1,'2024-05-24 17:57:33','2024-05-24 17:57:36','c89686e4-ee56-4590-bf61-234721511c4c'),(15405,15405,1,'SHEA','shea','resource-sources/shea',NULL,1,'2024-05-24 17:58:49','2024-05-24 18:01:39','8aca7235-ed23-4502-ab7f-019a9b2e713c'),(15522,15522,1,'IDSA','idsa','resource-sources/idsa',NULL,1,'2024-05-24 18:00:02','2024-05-24 18:01:39','e82b1701-1a94-4dfe-91e0-00721a9877d6'),(15699,15699,1,'IDSA; SHEA','idsa-shea','resource-sources/idsa-shea',NULL,1,'2024-05-24 18:01:14','2024-05-24 18:01:39','788b3034-ebdc-49a7-91ed-9416dfcbcb89'),(15928,15928,1,'Epidemic Keratoconjunctivitis (EKC)','ekc-2','diseases-pathogens/ekc-2',NULL,1,'2024-05-24 18:03:54','2024-05-24 18:03:54','702787f2-dadb-4387-9fb9-f939bb6c6f7a'),(15929,15929,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as severe viral conjunctivitis or pink eye</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"EKC Resources\"}',1,'2024-05-24 18:03:54','2024-05-24 18:03:54','67d0f944-ceda-411f-8213-4d92cba2d5c9'),(15930,15930,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:03:54','2024-05-24 18:03:54','aca9c319-8e1a-4e1e-8bff-56e9818077bf'),(15931,15931,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>EKC is a highly contagious viral conjunctivitis (\\\"pink eye\\\") that can result in reduced vision. EKC is typically caused by adenoviruses. Transmission can occur in healthcare settings via contact with contaminated hands, surfaces, equipment, or medical products. Outbreaks are often associated with eye care settings, with investigations of clinic transmission often pointing to contamination of multi-use drops and tonometer devices. Clustered EKC infections should be reported to the appropriate state or local health department.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About EKC\"}',1,'2024-05-24 18:03:54','2024-05-24 18:03:54','7b3cb1ac-a82d-4e2d-98a0-e00a8f602d81'),(15932,15932,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:03:54','2024-05-24 18:03:54','e1c87e27-cffb-4396-b1c0-cec64b9f2ee6'),(15933,15933,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key measures to prevent and control EKC transmission in healthcare settings include: - strict adherence to hand hygiene, - use of disposable gloves for contact with eye secretions, - effective environmental cleaning and disinfection of surfaces and equipment, - using single use equipment and eye drops, - cohorting of suspected conjunctivitis patients, and - work restrictions for symptomatic healthcare personnel.</p>\"}',1,'2024-05-24 18:03:54','2024-05-24 18:03:54','4c3112c0-017f-4cee-988e-20c2e70eca4d'),(15934,15934,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:03:54','2024-05-24 18:03:54','34aef98e-e5ac-4ce6-89e7-59bf4e462872'),(15935,15935,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Epidemic Keratoconjunctivitis\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/conjunctivitis/hcp/infection-control-ekc/?CDC_AAref_Val=https://www.cdc.gov/conjunctivitis/clinical/prevent-ekc.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides cleaning and disinfection guidance for opthalmologic healthcare settings.\"}',1,'2024-05-24 18:03:54','2024-05-24 18:03:54','f334a2f6-83b0-4bbf-8ce0-bd55c4b85225'),(15936,15936,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:03:55','2024-05-24 18:03:55','fd4b87c7-4eff-4ba8-a2bd-11ff89f594ca'),(15937,15937,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-24 18:03:55','2024-05-24 18:03:55','ceda493f-b734-419c-82a7-6479f31d13d8'),(15938,15938,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:03:55','2024-05-24 18:03:55','9d190a80-25d2-4b98-946a-fbcb3ec7e6c9'),(15939,15939,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This is a ready-to-use template to document epidemic keratoconjunctivitis (EKC) outbreak information.\"}',1,'2024-05-24 18:03:55','2024-05-24 18:03:55','aea37609-9877-48c4-b895-c40e48d16983'),(15940,15940,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:03:55','2024-05-24 18:03:55','5ac3ee6c-980b-455a-a91a-a53418627627'),(15941,15941,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Epidemic Keratoconjunctivitis (EKC) Outbreak Patient Letter\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides sample language for healthcare facilities communicating with patients on epidemic keratoconjunctivitis (EKC) outbreaks.\"}',1,'2024-05-24 18:03:55','2024-05-24 18:03:55','d907c95b-aff6-46ae-b354-44b0b4f1e05e'),(15942,15942,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:03:55','2024-05-24 18:03:55','b0a5e7f9-9794-441a-aeef-536e6d58e9e2'),(15943,15943,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Adenovirus-Associated Epidemic Keratoconjunctivitis Outbreaks — Four States, 2008–2010\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2013-08-16 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6232a1.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC MMWR summarizes EKC investigations across four states and recommends outbreak control measures.\"}',1,'2024-05-24 18:03:55','2024-05-24 18:03:55','c931cefb-93a8-4187-ad26-b5f2467fe553'),(15944,15944,1,'Legionella','legionella','diseases-pathogens/legionella',NULL,1,'2024-05-24 18:05:00','2024-05-24 18:06:30','7c42b26b-db41-4fe4-8f43-c1bcf3ee0e9e'),(15957,15957,1,'Epidemic Keratoconjunctivitis (EKC)','ekc-2','diseases-pathogens/ekc-2',NULL,1,'2024-05-24 18:05:35','2024-05-24 18:05:35','37e5d558-2938-4e56-915a-c8b5ea105a72'),(15958,15958,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as severe viral conjunctivitis or pink eye</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Epidemic Keratoconjunctivitis (EKC)\"}',1,'2024-05-24 18:05:35','2024-05-24 18:05:35','675e9a31-58fc-4086-876c-d16ce6e5c72d'),(15959,15959,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:35','2024-05-24 18:05:35','8b739e31-540d-439d-b219-6154f68ee4ce'),(15960,15960,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Epidemic Keratoconjunctivitis\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/conjunctivitis/hcp/infection-control-ekc/?CDC_AAref_Val=https://www.cdc.gov/conjunctivitis/clinical/prevent-ekc.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides cleaning and disinfection guidance for opthalmologic healthcare settings.\"}',1,'2024-05-24 18:05:35','2024-05-24 18:05:35','42174912-ee86-4875-a7f6-d9d758145823'),(15961,15961,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:35','2024-05-24 18:05:35','e2e19b38-3de9-42b1-9975-3dd8327491e0'),(15962,15962,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-24 18:05:35','2024-05-24 18:05:35','c0c019f2-3134-4fc7-8dcc-51f09d1686c1'),(15963,15963,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:35','2024-05-24 18:05:35','4775fede-0671-4beb-b30f-0186d76955c8'),(15964,15964,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This is a ready-to-use template to document epidemic keratoconjunctivitis (EKC) outbreak information.\"}',1,'2024-05-24 18:05:35','2024-05-24 18:05:35','0ab63897-a189-4efb-b825-63847cd9eb38'),(15965,15965,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:35','2024-05-24 18:05:35','7be4e083-53af-4a5b-a7e2-670830b0f30f'),(15966,15966,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Epidemic Keratoconjunctivitis (EKC) Outbreak Patient Letter\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides sample language for healthcare facilities communicating with patients on epidemic keratoconjunctivitis (EKC) outbreaks.\"}',1,'2024-05-24 18:05:35','2024-05-24 18:05:35','062d4a6b-5766-4d25-9daf-57b251ae5926'),(15967,15967,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:35','2024-05-24 18:05:35','930d6292-ec4b-4781-ba3d-2b7537f71b3d'),(15968,15968,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Adenovirus-Associated Epidemic Keratoconjunctivitis Outbreaks — Four States, 2008–2010\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2013-08-16 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6232a1.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC MMWR summarizes EKC investigations across four states and recommends outbreak control measures.\"}',1,'2024-05-24 18:05:35','2024-05-24 18:05:35','d3bd0a11-3b4f-4d6c-af2c-1ffaa894b5cd'),(15981,15981,1,'COVID-19','covid-19','diseases-pathogens/covid-19',NULL,1,'2024-05-24 18:05:47','2024-05-24 18:05:47','4472abca-1234-4e23-b933-29a102461f7f'),(15982,15982,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called SARS-CoV-2 infection</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19\"}',1,'2024-05-24 18:05:47','2024-05-24 18:05:47','e75fcf9a-5fab-4404-8178-b87120e2be79'),(15983,15983,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:47','2024-05-24 18:05:47','89a55f22-c214-4cfd-bfe8-de5c9030a411'),(15984,15984,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/wp-content/uploads/2024/01/COVID-19-HC-Outbreak-Definition-Guidance_January-2024.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"These proposed investigation/reporting thresholds and outbreak definitions are provided to support the early detection of possible outbreaks and timely intervention to prevent transmission.\"}',1,'2024-05-24 18:05:47','2024-05-24 18:05:47','2cf9404c-2154-4f43-a975-4b28f5084070'),(15985,15985,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:47','2024-05-24 18:05:47','114453b7-e10e-4217-a0ad-13502ed7fba1'),(15986,15986,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Preventing Transmission of Viral Respiratory Pathogens in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/viral-respiratory-prevention/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/viral/prevent-viral.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource, published at the start of the 2023-2024 respiratory virus season, provides guidance for preventing all viral respiratory pathogens,  including influenza virus and SARS-CoV-2 infection, in healthcare settings.\"}',1,'2024-05-24 18:05:47','2024-05-24 18:05:47','553be700-27b7-4dbc-86e7-dcb66df4aad1'),(15987,15987,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:47','2024-05-24 18:05:47','fb03d432-ce4e-4c9d-b914-01fb7adcfd5a'),(15988,15988,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Respiratory Pathogens Toolkit\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/long-term-care-facilities/hcp/respiratory-virus-toolkit/?CDC_AAref_Val=https://www.cdc.gov/longtermcare/prevention/viral-respiratory-toolkit.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit was published at the start of the 2023-2024 respiratory virus season, alongside general healthcare setting guidance, and serves as a setting-specific resource for nursing homes and long-term care facilities.\"}',1,'2024-05-24 18:05:47','2024-05-24 18:05:47','2e4c2cce-8c7e-4d6a-80eb-a8efcfcc8538'),(15989,15989,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:47','2024-05-24 18:05:47','51267d07-5141-49fe-ad5e-8e973ad6c9df'),(15990,15990,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency. This guidance provides a framework for facilities to implement select infection prevention and control practices based on their individual circumstances.\"}',1,'2024-05-24 18:05:47','2024-05-24 18:05:47','728d5487-8301-4231-8084-3998dfa60eab'),(15991,15991,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:05:47','2024-05-24 18:05:47','d88c9e9f-a88c-4d91-86cc-f13eb569f832'),(15992,15992,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"National Healthcare Safety Network (NHSN): COVID-19 Modules and Dashboards\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/nhsn/covid19/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes NHSN COVID-19 reference materials relevant to hospital, long-term care facility, and dialysis facility personnel.\"}',1,'2024-05-24 18:05:47','2024-05-24 18:05:47','162e6130-b2dd-4b42-91b1-b88a1dd32145'),(15993,15993,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"L\"}',1,'2024-05-24 18:06:25','2024-05-24 18:06:25','a85dd662-b9db-4103-9c90-89fba0f38b3d'),(15994,15994,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:06:25','2024-05-24 18:06:25','ee424a96-5dc8-42b9-8785-5829c07e2e5d'),(15995,15995,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:06:26','2024-05-24 18:06:26','c57ab61f-4acc-4b8a-823b-cf0da185500a'),(15996,15996,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Legionella\"}',1,'2024-05-24 18:06:39','2024-05-24 18:06:39','9e142078-bcaa-4d98-9658-ed987430484b'),(15997,15997,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Legionella R\"}',1,'2024-05-24 18:06:56','2024-05-24 18:06:56','51b338af-5a60-4efd-bdd1-bbe14dcbace5'),(15998,15998,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Legionella Resourc\"}',1,'2024-05-24 18:06:57','2024-05-24 18:06:57','521d91fa-d0bd-49e0-8a66-86139ce5102a'),(15999,15999,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Legionella Resources\"}',1,'2024-05-24 18:06:58','2024-05-24 18:06:58','5c41a89e-73bc-4ead-9c9b-6e05a39b13ac'),(16010,16010,1,NULL,'__temp_auhjvbwtkmvcoxtjmqpqjnvsbomymirchbir',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Legionnaires’ disease</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Legionella\"}',1,'2024-05-24 18:07:34','2024-06-13 13:50:58','6f87903a-316a-4789-b9c1-e8efa381407a'),(16011,16011,1,NULL,NULL,NULL,'{\"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 18:07:43','2024-05-24 18:07:43','1c4ead9c-21f7-43cf-907a-608ebb3efc5f'),(16012,16012,1,NULL,NULL,NULL,'{\"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 18:07:47','2024-05-24 18:07:47','f6443607-b935-44fe-bf2f-a0e9dd00e931'),(16013,16013,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 18:07:59','2024-05-24 18:07:59','ec4fd97c-f277-4ba3-abf6-a8c2cdae0604'),(16014,16014,1,'Mpox','mpox','diseases-pathogens/mpox',NULL,1,'2024-05-24 18:08:01','2024-05-24 18:08:05','fab75c30-9349-43a7-bdcc-9bc231d19202'),(16015,16015,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:08:05','2024-05-24 18:08:05','c1597694-d6e2-4609-9413-bb57e03c0ed7'),(16016,16016,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:08:05','2024-05-24 18:08:05','83e31ee3-4a34-408e-bf29-6e2fc09a23bc'),(16017,16017,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Mpox\"}',1,'2024-05-24 18:08:08','2024-05-24 18:08:08','94593de8-1829-46d8-9805-22e0e016d762'),(16018,16018,1,'Legionella pneumophila',NULL,NULL,NULL,1,'2024-05-24 18:08:40','2024-05-24 18:08:40','84c6f617-93d4-4381-9177-93b0749e8a3f'),(16019,16019,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 18:08:40','2024-06-03 20:18:49','6c983fd6-2b58-4166-a1a6-01da9907b0a9'),(16020,16020,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Formerly known as monkeypox</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Mpox\"}',1,'2024-05-24 18:08:42','2024-05-24 18:08:42','ce469627-b31d-4b21-9a2a-506295236523'),(16021,16021,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Formerly known as monkeypox</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Mpox\"}',1,'2024-05-24 18:08:43','2024-05-24 18:08:43','36a6ad46-4f9c-4f60-bd71-a8a945b86ec1'),(16022,16022,1,NULL,NULL,NULL,'{\"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 18:08:51','2024-05-24 18:08:51','b13f576a-a839-4722-ae59-ee86895ca690'),(16023,16023,1,NULL,NULL,NULL,'{\"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 18:08:53','2024-05-24 18:08:53','afba7089-cec9-419c-ac2b-5f1e9048b168'),(16024,16024,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 18:08:57','2024-05-24 18:08:57','52727db0-d502-46bf-9af5-75bf0d78d5e3'),(16025,16025,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:09:08','2024-05-24 18:09:08','437105a1-723d-454a-a585-677d735b3dda'),(16026,16026,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:09:19','2024-05-24 18:09:19','61c35a17-3497-4966-8b5d-edf6b2a6f4f5'),(16027,16027,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:09:19','2024-05-24 18:09:19','a4ea3682-3607-46a2-99d4-757a83825a53'),(16028,16028,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:09:24','2024-05-24 18:09:24','e65e8d1c-412f-4b41-9491-b546346673ab'),(16029,16029,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Legionnaires’ disease is a serious type of pneumonia (lung infection) caused by <i>Legionella </i>bacteria. Outbreaks are commonly associated with buildings or structures that have complex water systems, including healthcare facilities like nursing homes and hospitals.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Legionella\"}',1,'2024-05-24 18:09:24','2024-05-24 18:09:24','65a82c94-3180-41c9-b496-a35bb469f124'),(16030,16030,1,'Mpox Header',NULL,NULL,NULL,1,'2024-05-24 18:09:30','2024-05-24 18:09:30','70256a89-033c-4464-97b8-48482b3fa228'),(16031,16031,1,NULL,'__temp_fzxvhydwsbtttpfzpeypnnzdsccyvjwghnkc',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Formerly known as monkeypox</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Mpox\"}',1,'2024-05-24 18:09:31','2024-07-31 20:37:29','070d0832-31c4-4ed2-9bf9-c8904081742a'),(16032,16032,1,'Mpox Header',NULL,NULL,NULL,1,'2024-05-24 18:09:35','2024-05-24 18:09:35','6f179666-cfb3-48f2-83e7-09d99a472444'),(16033,16033,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 18:09:35','2024-06-03 20:18:49','de3a0387-7803-473d-92b2-2304e10bd352'),(16034,16034,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:10:58','2024-05-24 18:10:58','6cc3cd13-37a8-4f03-9a79-ad039413441a'),(16035,16035,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:10:58','2024-05-24 18:10:58','562bf978-22e3-4a9c-b4db-011fe7b706cf'),(16036,16036,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:10:58','2024-05-24 18:10:58','a94dc9d4-5fd3-4b13-b2bd-7bdad4885d6a'),(16037,16037,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:11:01','2024-05-24 18:11:01','1b56c192-fa99-4fa3-a5cf-ff6f93dbbef2'),(16038,16038,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\"}',1,'2024-05-24 18:11:01','2024-05-24 18:11:01','80b48281-2ada-4f5a-8b88-fee8aa87f69d'),(16039,16039,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:11:16','2024-05-24 18:11:16','81264ddd-d93d-40a3-96e7-542d29c93dce'),(16040,16040,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About\"}',1,'2024-05-24 18:11:16','2024-05-24 18:11:16','44f297a6-38b2-4b5e-b284-102d6d41959c'),(16041,16041,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:11:20','2024-05-24 18:11:20','6203b1a8-bb6e-4d51-89d5-dae071bc83e4'),(16042,16042,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:11:20','2024-05-24 18:11:20','5069d8de-737d-46a4-b348-affe35e2a3bd'),(16043,16043,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:07','2024-05-24 18:12:07','2a17835f-31af-4a78-af70-f2a9cb39e93e'),(16044,16044,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 18:12:07','2024-05-24 18:12:07','79a30503-4a14-4e9b-9760-50b8cc6c91d0'),(16045,16045,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:08','2024-05-24 18:12:08','6df1b6c4-5a79-45d4-a0aa-d561a9c28672'),(16046,16046,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:08','2024-05-24 18:12:08','f74b85ea-1233-4913-bd56-f15c6a9434a2'),(16047,16047,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:09','2024-05-24 18:12:09','13024ae9-7258-4501-a580-27710b04507e'),(16048,16048,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 18:12:09','2024-05-24 18:12:09','0dd72340-b487-4069-94a3-459baed2b9ba'),(16049,16049,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:10','2024-05-24 18:12:10','4eb6e2c0-b0c2-4595-bde5-ba2cf2f7fa47'),(16050,16050,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:10','2024-05-24 18:12:10','0869e476-2269-4e62-97d9-3a40924af5db'),(16051,16051,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:10','2024-05-24 18:12:10','d31affc7-bc54-4349-9579-4be614d6d38e'),(16052,16052,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:10','2024-05-24 18:12:10','dabf775c-872f-4067-ab13-deb80e6aa646'),(16053,16053,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:11','2024-05-24 18:12:11','e1ca0ba3-4594-45e0-b6f5-522bf60885c6'),(16054,16054,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:11','2024-05-24 18:12:11','c3ab9e6c-3dca-4f87-a48c-0d793d8d06e3'),(16055,16055,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:12','2024-05-24 18:12:12','693d70a0-f8b4-46fb-beeb-bd7723460295'),(16056,16056,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:12','2024-05-24 18:12:12','8b6d5e12-1339-4683-a1ad-0b3b708cc7ea'),(16057,16057,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:12','2024-05-24 18:12:12','cd15875d-b8e6-4b8e-809e-e2ca82744a3f'),(16058,16058,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:13','2024-05-24 18:12:13','a7374d7d-cb58-4b73-b718-75b8e55c95b5'),(16059,16059,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:13','2024-05-24 18:12:13','4c7d100c-1ec8-4622-a49f-f9086b48a809'),(16060,16060,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:13','2024-05-24 18:12:13','2abefdde-4990-4c49-b258-98fe54850dfc'),(16061,16061,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:14','2024-05-24 18:12:14','fa340a94-f064-415d-a19c-43b9f43a6deb'),(16062,16062,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:14','2024-05-24 18:12:14','89645764-d1c3-4e2c-9e5b-014bea148c52'),(16063,16063,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:14','2024-05-24 18:12:14','648093a9-430c-4484-8da8-fa890d5e89be'),(16064,16064,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\"}',1,'2024-05-24 18:12:14','2024-05-24 18:12:14','8cc1ae97-45c2-45ea-9f55-601c5a800186'),(16065,16065,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:15','2024-05-24 18:12:15','e0db1c10-4a88-4cfd-8ab5-33344ce965c9'),(16066,16066,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:15','2024-05-24 18:12:15','4628f059-7c77-48e0-a6d5-742674f9bdd5'),(16067,16067,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:16','2024-05-24 18:12:16','1cc64cfb-329a-43aa-b43e-bc6841a83c9a'),(16068,16068,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:16','2024-05-24 18:12:16','53ee2fc8-a7cd-4224-b742-51842e20f38e'),(16069,16069,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:17','2024-05-24 18:12:17','6e31c763-3c19-47fe-953d-21924df62317'),(16070,16070,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:17','2024-05-24 18:12:17','81ea8538-2251-460f-b2ec-0cabce885b9e'),(16071,16071,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:17','2024-05-24 18:12:17','4cc56f9a-061e-4e6d-9bbb-8908f3fc5cf7'),(16072,16072,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:17','2024-05-24 18:12:17','61a5cd9c-715b-4fb3-a94b-994d39bf5da9'),(16073,16073,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:18','2024-05-24 18:12:18','6d377e57-58a3-46f8-8e47-a448bcd07558'),(16074,16074,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:18','2024-05-24 18:12:18','0dc6f904-f57b-4292-9f31-430283d8a517'),(16075,16075,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:19','2024-05-24 18:12:19','0b444d5d-ba30-49ab-974a-3e3fa49a3f9f'),(16076,16076,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:19','2024-05-24 18:12:19','ffe07065-657b-4f01-99e7-82555bb7a907'),(16077,16077,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:21','2024-05-24 18:12:21','4626c785-6af9-40b7-b550-028218226206'),(16078,16078,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:21','2024-05-24 18:12:21','c5cb5b65-618c-4c90-b2b5-add44e9dbaaf'),(16079,16079,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:24','2024-05-24 18:12:24','39b1f7ef-5b12-4c48-bd65-a0ce51ee59cb'),(16080,16080,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\"}',1,'2024-05-24 18:12:24','2024-05-24 18:12:24','7058a9ee-c2b1-41b1-b267-a5606912ccad'),(16081,16081,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:25','2024-05-24 18:12:25','cff2b03b-b8f9-40f4-8675-7c001fc646bf'),(16082,16082,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:25','2024-05-24 18:12:25','f8333058-bca7-4ec3-adaf-e943b273579f'),(16083,16083,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:25','2024-05-24 18:12:25','63be4f7f-3181-46fb-ba07-acd72ee42295'),(16084,16084,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\"}',1,'2024-05-24 18:12:25','2024-05-24 18:12:25','24873ae9-19a8-486b-a257-d93b7728ff1f'),(16085,16085,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:26','2024-05-24 18:12:26','cbe66e0a-56da-4b02-9bf5-fd381b728554'),(16086,16086,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:26','2024-05-24 18:12:26','45c68b4e-fbd5-49b6-9d93-f36441a79357'),(16087,16087,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:26','2024-05-24 18:12:26','a1d8b118-d230-4eb2-9e1a-c44430366e90'),(16088,16088,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:26','2024-05-24 18:12:26','f6b885b2-72c1-4d4d-9932-ef444e383d0f'),(16089,16089,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:27','2024-05-24 18:12:27','a57725b4-2192-4742-ac3b-001f847e70e6'),(16090,16090,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:27','2024-05-24 18:12:27','7884a989-7400-4713-994e-9ce99520b7cb'),(16091,16091,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:28','2024-05-24 18:12:28','22c63271-9a14-44e4-bb4b-8a5919aea879'),(16092,16092,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:28','2024-05-24 18:12:28','dabd2ed3-2b9c-4c9b-9e3f-a1f9aa80e5a6'),(16093,16093,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:29','2024-05-24 18:12:29','c5198edd-fb38-4ba2-9d29-8d80dd8e099f'),(16094,16094,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:29','2024-05-24 18:12:29','d95f6249-3772-4314-a49c-d4f4294ce48c'),(16095,16095,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:29','2024-05-24 18:12:29','3427a6f8-3e11-45b2-9339-c9d68c146e4f'),(16096,16096,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html\"}',1,'2024-05-24 18:12:29','2024-05-24 18:12:29','df558241-ac57-4772-97db-cfd97df348fc'),(16097,16097,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:30','2024-05-24 18:12:30','76495771-a3d2-4270-8ae0-25b00fe2e2c1'),(16098,16098,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:30','2024-05-24 18:12:30','fc3af051-fce5-4469-9557-11038c6aad20'),(16099,16099,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:31','2024-05-24 18:12:31','2ff3e2a5-80b3-4b5c-a2f7-966b4c846305'),(16100,16100,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html\"}',1,'2024-05-24 18:12:31','2024-05-24 18:12:31','81313373-b9c2-4e12-b042-87d6aad16fd1'),(16101,16101,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:31','2024-05-24 18:12:31','dd2a5a2e-d0c9-4419-82b8-040e947059c7'),(16102,16102,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:31','2024-05-24 18:12:31','c7e33425-7f33-40f3-ab55-5c960f4ba1f1'),(16103,16103,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:32','2024-05-24 18:12:32','d4a7eb9e-ef3e-4900-ba86-d9a23b241553'),(16104,16104,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:32','2024-05-24 18:12:32','1b8b942d-9968-49d4-99cd-284409e4f263'),(16105,16105,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:33','2024-05-24 18:12:33','29eec8df-982e-480a-8756-47e57efe343f'),(16106,16106,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:33','2024-05-24 18:12:33','2f4bd0d6-86da-44ad-96a9-f5413b4b5e71'),(16107,16107,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:33','2024-05-24 18:12:33','90891ca4-bd56-4fce-aafd-71142baa1d07'),(16108,16108,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html\"}',1,'2024-05-24 18:12:33','2024-05-24 18:12:33','bac35615-3b08-42fb-ad48-f65521b578a7'),(16109,16109,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:34','2024-05-24 18:12:34','51df6cf8-75b4-406a-8255-b561b7dacccf'),(16110,16110,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:34','2024-05-24 18:12:34','6054b19d-f3f3-4ba1-b35e-5fff5001dedd'),(16111,16111,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:35','2024-05-24 18:12:35','183a20a3-4050-4179-acdd-e06ea89c985b'),(16112,16112,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:35','2024-05-24 18:12:35','19c95f09-3092-4ec8-abc9-edf8b31d5bfb'),(16113,16113,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:35','2024-05-24 18:12:35','d3ea266d-f8c5-4fe9-a986-2b35a068fd9f'),(16114,16114,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:35','2024-05-24 18:12:35','647ed5d0-9975-45e1-a7dc-50d6b6a83aaa'),(16115,16115,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:36','2024-05-24 18:12:36','248df718-e7bd-4fa6-bb0c-2ed6d4da4d38'),(16116,16116,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:36','2024-05-24 18:12:36','e7d33eb7-14a6-4a2a-991b-6698ddbd2bbe'),(16117,16117,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:37','2024-05-24 18:12:37','20a31756-08b8-48a8-bc23-dec2c23a1c3c'),(16118,16118,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:37','2024-05-24 18:12:37','8b4fe0cc-9ad8-4658-b80d-c69e83f53e41'),(16119,16119,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:38','2024-05-24 18:12:38','fd9b06ea-8814-48a9-8e37-1dcc58003394'),(16120,16120,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:38','2024-05-24 18:12:38','5902b102-f464-4fa6-8b15-8d66e20b12ec'),(16121,16121,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:38','2024-05-24 18:12:38','e160005b-46c0-4d97-8416-f54266f37a22'),(16122,16122,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:38','2024-05-24 18:12:38','2375d4d4-a05d-43c7-9d8a-6645df71cff9'),(16123,16123,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:39','2024-05-24 18:12:39','177f4a6e-b75c-4840-b1ae-87d90a45ccad'),(16124,16124,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:39','2024-05-24 18:12:39','288d8d65-3ba0-4cfc-a0e8-27f0d4799be1'),(16125,16125,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:40','2024-05-24 18:12:40','001ea0be-94de-4268-819a-4b2723f77efa'),(16126,16126,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:40','2024-05-24 18:12:40','97081743-7d95-45d1-8734-e08ab76f8c69'),(16127,16127,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:40','2024-05-24 18:12:40','fedac883-e498-480d-b7db-960c38f5f734'),(16128,16128,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:40','2024-05-24 18:12:40','78317cfa-36c9-41a4-afac-470114de8499'),(16129,16129,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:41','2024-05-24 18:12:41','d9793c3a-0580-454c-b258-2d784c0d8643'),(16130,16130,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:41','2024-05-24 18:12:41','2b24412b-834f-4087-a267-bd2de44effb1'),(16131,16131,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:42','2024-05-24 18:12:42','e5c3042b-ae6c-4015-85be-4256a567af34'),(16132,16132,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:42','2024-05-24 18:12:42','d50f0775-abe9-435f-b733-385c7d2dccc6'),(16133,16133,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:42','2024-05-24 18:12:42','e4c5bea3-6b30-4849-8c7a-53d10a49c5fd'),(16134,16134,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:42','2024-05-24 18:12:42','265d4d9d-2df2-4ba1-aaa5-bdf396fdb641'),(16135,16135,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:43','2024-05-24 18:12:43','41baa2ba-d60a-4b75-9ca1-94c1ef1e5f65'),(16136,16136,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:43','2024-05-24 18:12:43','d412bd38-c591-4725-a852-93e1cd9b1897'),(16137,16137,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:44','2024-05-24 18:12:44','9456f76a-f626-4ecb-9367-4fe3a38737b4'),(16138,16138,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:44','2024-05-24 18:12:44','e0b07f58-3da2-4534-b239-13bddb467c70'),(16139,16139,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:44','2024-05-24 18:12:44','a430163b-1db7-4b8e-935c-934c180dc2e1'),(16140,16140,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html\"}',1,'2024-05-24 18:12:44','2024-05-24 18:12:44','840d2a33-2602-4dd1-9d5c-4d783968820f'),(16141,16141,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:44','2024-05-24 18:12:44','6d3e0537-67b9-43f4-b873-a563e67a21c2'),(16142,16142,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 18:12:44','2024-05-24 18:12:44','9176eeee-dfdf-457a-9b4e-ef1985f9ba5d'),(16143,16143,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:45','2024-05-24 18:12:45','0afeeebd-4cac-45c3-beef-d9c779b1545f'),(16144,16144,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html\"}',1,'2024-05-24 18:12:45','2024-05-24 18:12:45','3502e96d-5022-41a5-8872-74e018674bcd'),(16145,16145,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:45','2024-05-24 18:12:45','4c87b205-ffc6-4d48-8d26-a62e7d4a20fc'),(16146,16146,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 18:12:45','2024-05-24 18:12:45','bbd70953-5444-4811-80b8-9b26d93084ee'),(16147,16147,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:45','2024-05-24 18:12:45','33810f7b-c8bc-4475-8129-89b82e0e4499'),(16148,16148,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:45','2024-05-24 18:12:45','f5701b63-efd3-4f3d-9e54-6934e81eb3f4'),(16149,16149,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:46','2024-05-24 18:12:46','e692e26a-c487-45c2-8129-374539837186'),(16150,16150,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:46','2024-05-24 18:12:46','28a5d302-3e61-4c7e-9f5a-a6571b6d703e'),(16151,16151,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:47','2024-05-24 18:12:47','6ef85ce8-a1a4-44a1-87ea-e426fd159331'),(16152,16152,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:47','2024-05-24 18:12:47','0ac39cce-f7e6-442d-a476-f5079c648861'),(16153,16153,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:47','2024-05-24 18:12:47','9f7194a7-b1b4-43ec-8282-f71cfa93a0bf'),(16154,16154,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:47','2024-05-24 18:12:47','96f06cec-46b8-41a5-be62-83dfb24877b5'),(16155,16155,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:48','2024-05-24 18:12:48','95e373fd-26d2-40ed-bfc5-f20c0996498a'),(16156,16156,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:48','2024-05-24 18:12:48','f02cbd68-2a8c-4b8c-a913-7c84cb5b574c'),(16157,16157,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:49','2024-05-24 18:12:49','c36a6050-4d0e-43e6-8fc3-41626c58e109'),(16158,16158,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:49','2024-05-24 18:12:49','4900e6af-458f-45d6-ad57-84663d14b1f6'),(16159,16159,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:49','2024-05-24 18:12:49','44ca07a1-a7ff-44f2-a83f-31dd81e746c7'),(16160,16160,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:49','2024-05-24 18:12:49','94ec7983-7645-457b-b9a6-af9118b14a87'),(16161,16161,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:50','2024-05-24 18:12:50','e1a8b730-c20f-494e-a45f-3bed59e2fa4b'),(16162,16162,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:50','2024-05-24 18:12:50','b6adc404-050a-4d8a-9d9d-97d62b7ff1c2'),(16163,16163,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:50','2024-05-24 18:12:50','7a1f7393-382c-4e0c-824a-717241b7a436'),(16164,16164,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:50','2024-05-24 18:12:50','6c957616-3db0-4899-8887-d4796802afda'),(16165,16165,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:51','2024-05-24 18:12:51','8a53453a-bcf1-4900-828e-e5d2e0c7d9ef'),(16166,16166,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:51','2024-05-24 18:12:51','462e2a3b-e344-4827-96f5-74254a37ab46'),(16167,16167,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:51','2024-05-24 18:12:51','b410a537-6de9-4412-a4c3-dc6f93f82c33'),(16168,16168,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html\"}',1,'2024-05-24 18:12:51','2024-05-24 18:12:51','dafc5b24-a8ee-4a24-9ac3-ebf8201b1d10'),(16169,16169,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:51','2024-05-24 18:12:51','4704b95d-2737-401e-a511-82c6f90ea9f7'),(16170,16170,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Mpox Infection Control Resource Page\"}',1,'2024-05-24 18:12:51','2024-05-24 18:12:51','d025c58e-f501-4935-a7f4-cb03842034a5'),(16171,16171,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:52','2024-05-24 18:12:52','cddf8230-6188-4dbd-b2b2-c2f6927c3e43'),(16172,16172,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:52','2024-05-24 18:12:52','40271862-0298-4004-a137-224df124fc38'),(16173,16173,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:53','2024-05-24 18:12:53','3e84e904-6a7d-4e9e-8099-c4379f885325'),(16174,16174,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:53','2024-05-24 18:12:53','fa4f260d-0f9f-4e93-9c20-863d50e64d46'),(16175,16175,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:54','2024-05-24 18:12:54','4f3025e6-d7cf-4de3-8a98-67af374733ba'),(16176,16176,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:54','2024-05-24 18:12:54','53054861-0ace-4dd5-98c8-7b70b575f2a3'),(16177,16177,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:55','2024-05-24 18:12:55','bb5ea36a-cb59-4063-96e6-f57c132dbbd2'),(16178,16178,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:55','2024-05-24 18:12:55','168bf764-c355-4b38-838a-d314f15bb9a4'),(16179,16179,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:56','2024-05-24 18:12:56','237ff7d1-d008-435b-adf8-1aed38ecaab6'),(16180,16180,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:56','2024-05-24 18:12:56','dd5cbecc-1a69-46e6-bb56-624363fc453d'),(16181,16181,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:57','2024-05-24 18:12:57','74315abd-f0d5-4b67-8a53-4f6e71bcea92'),(16182,16182,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:57','2024-05-24 18:12:57','4a8bd835-6560-4dbe-9522-befd9b5e8df6'),(16183,16183,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:57','2024-05-24 18:12:57','2245d369-2f9c-4408-b301-22d681f954e6'),(16184,16184,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:57','2024-05-24 18:12:57','5fd0fd30-6b32-4fda-9fc6-60ac9772b92f'),(16185,16185,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:58','2024-05-24 18:12:58','58002c01-13d6-463f-8a63-77e860ccea24'),(16186,16186,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:58','2024-05-24 18:12:58','b4be3666-065b-4703-be0e-d4d2af807f18'),(16187,16187,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:59','2024-05-24 18:12:59','1571f3d6-38af-408c-8870-2295a9e08a16'),(16188,16188,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:59','2024-05-24 18:12:59','b509fa2d-c147-4031-820f-142f1efb4a19'),(16189,16189,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:12:59','2024-05-24 18:12:59','7f4eb572-ede5-415a-8ad5-2ac541a5b162'),(16190,16190,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:12:59','2024-05-24 18:12:59','f2c4349f-1033-4f83-b906-90748ac94ee2'),(16191,16191,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:00','2024-05-24 18:13:00','721c4517-a1b2-4ea4-9c2f-ea3c55158838'),(16192,16192,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:00','2024-05-24 18:13:00','f7a40ce6-b108-45bf-b2b2-c99462d86ee1'),(16193,16193,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:01','2024-05-24 18:13:01','14b5895f-b20d-4f2e-96c3-8e202f4ad42b'),(16194,16194,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:01','2024-05-24 18:13:01','b38967be-8af0-4af8-890a-f2edad710a7b'),(16195,16195,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:01','2024-05-24 18:13:01','843a9b41-da32-4a7d-936d-1aaab234f8cb'),(16196,16196,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html\"}',1,'2024-05-24 18:13:01','2024-05-24 18:13:01','81c65aae-8bee-4966-9fba-c87141c3e48f'),(16197,16197,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:01','2024-05-24 18:13:01','62ee198e-14d4-4c58-b21e-2fafb82c6579'),(16198,16198,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Mpox Infection Control Resource Page\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://apic.org/monkeypox/\"}',1,'2024-05-24 18:13:01','2024-05-24 18:13:01','7c9a8b12-260c-41ce-96ce-7194aa7d2766'),(16199,16199,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:02','2024-05-24 18:13:02','0364e059-6318-4ee0-9577-f852acd40a35'),(16200,16200,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:02','2024-05-24 18:13:02','ca887cc6-cf28-4ebb-9a83-67e432fddada'),(16201,16201,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:03','2024-05-24 18:13:03','982e704b-7c45-4b02-815c-3c2667393a4e'),(16202,16202,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:03','2024-05-24 18:13:03','9e6147f2-4c87-4876-a79b-cc468f1ee699'),(16203,16203,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:04','2024-05-24 18:13:04','d1e4e50f-a0ed-4a6b-9d75-785978b918ee'),(16204,16204,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:04','2024-05-24 18:13:04','59ab3e11-9d42-43e3-b45a-841b8ebc1e3e'),(16205,16205,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:04','2024-05-24 18:13:04','5f3617eb-e0de-4e49-a474-bb8c71656abd'),(16206,16206,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:04','2024-05-24 18:13:04','19bec327-ad8e-4309-b5b9-8bfabe4e7329'),(16207,16207,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:05','2024-05-24 18:13:05','2a6dc134-7b1f-4d84-89c1-984e7b29b576'),(16208,16208,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:05','2024-05-24 18:13:05','842ba1e6-6e0e-4d7f-b63e-62b8e4fdf54f'),(16209,16209,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:06','2024-05-24 18:13:06','2c8fca7e-99df-4b0f-8c1f-1cee7916dec6'),(16210,16210,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:06','2024-05-24 18:13:06','925e8e3c-2815-4ff2-94c3-9db884ee28b3'),(16211,16211,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:07','2024-05-24 18:13:07','1494f94b-4455-4d47-a0f9-753591d31cfd'),(16212,16212,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:07','2024-05-24 18:13:07','9144682a-5271-4c32-be8c-3c0e5806f25b'),(16213,16213,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:08','2024-05-24 18:13:08','43fdd26c-907a-4a50-9a8b-94480b4b88d0'),(16214,16214,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:08','2024-05-24 18:13:08','8e890b3f-1d89-4a8a-9506-4ba38e8480a5'),(16215,16215,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:08','2024-05-24 18:13:08','6fba7856-d95d-4621-a9fb-4e6d3cb9eaf3'),(16216,16216,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:08','2024-05-24 18:13:08','6440dd2c-4935-4fe2-91c8-ec21f3260d3f'),(16217,16217,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:09','2024-05-24 18:13:09','39af288c-99bd-44aa-8d11-65cad296eb47'),(16218,16218,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:09','2024-05-24 18:13:09','96d44311-1de7-4633-a245-81fa4cfd34d2'),(16219,16219,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:10','2024-05-24 18:13:10','9d53b101-a613-4502-8b6c-a1a4f74f6364'),(16220,16220,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:10','2024-05-24 18:13:10','3533e8b8-3176-4ae4-8644-0c5b6c8986b1'),(16221,16221,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:11','2024-05-24 18:13:11','0d5a5278-9b19-40c2-84cf-d2fb3b4841ec'),(16222,16222,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:11','2024-05-24 18:13:11','2a8e19e8-a0e7-4829-88cb-af9096988cee'),(16223,16223,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:11','2024-05-24 18:13:11','4f2268d8-e6d1-443b-b3eb-c81fb35be15d'),(16224,16224,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:11','2024-05-24 18:13:11','b81d0dfe-8503-494a-aa5e-4a7b6fccfcf1'),(16225,16225,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:12','2024-05-24 18:13:12','388581cd-ab4b-439e-a596-735bf905a493'),(16226,16226,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:12','2024-05-24 18:13:12','0d3e01f8-dee2-4b59-9da7-99350e0bdc9d'),(16227,16227,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:13','2024-05-24 18:13:13','27b68e61-ffc1-40d5-995e-79e2ae942d90'),(16228,16228,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html\"}',1,'2024-05-24 18:13:13','2024-05-24 18:13:13','683feaae-e983-4a73-b6df-4c9b690cac18'),(16229,16229,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:13','2024-05-24 18:13:13','8561879d-4a59-4312-b307-e5b209356966'),(16230,16230,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Mpox Infection Control Resource Page\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://apic.org/monkeypox/\"}',1,'2024-05-24 18:13:13','2024-05-24 18:13:13','da634e69-dd49-4825-adb0-d2c98873fca3'),(16231,16231,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:14','2024-05-24 18:13:14','f0dd858a-7de5-4df3-b555-a177cee04467'),(16232,16232,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:14','2024-05-24 18:13:14','447b525a-a49c-4516-923b-ffb743f143a5'),(16233,16233,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:14','2024-05-24 18:13:14','4b56ae92-8b81-4194-a731-d412edfdcf02'),(16234,16234,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control of Mpox in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/poxvirus/mpox/clinicians/infection-control-healthcare.html\"}',1,'2024-05-24 18:13:14','2024-05-24 18:13:14','16e9411d-e3be-4f60-ad80-66e221fd51f8'),(16235,16235,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:14','2024-05-24 18:13:14','e27e6272-aeb6-4831-a218-a85c8d707ece'),(16236,16236,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Mpox Infection Control Resource Page\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://apic.org/monkeypox/\"}',1,'2024-05-24 18:13:14','2024-05-24 18:13:14','ade5db36-adb7-454e-ba16-66fb7bae84ef'),(16237,16237,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:15','2024-05-24 18:13:15','8e26a03c-fd33-40c4-9553-4c10ded1be51'),(16238,16238,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:15','2024-05-24 18:13:15','08468127-8fd7-43f2-89bd-7307b96440a1'),(16239,16239,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:16','2024-05-24 18:13:16','0964c2fe-7d66-46bf-b960-839a41a24303'),(16240,16240,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:16','2024-05-24 18:13:16','6385d37d-1f26-4b8c-af7c-92e45d719fae'),(16241,16241,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:17','2024-05-24 18:13:17','a649b8a9-7291-4eec-ba0c-45a4dc048d34'),(16242,16242,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:17','2024-05-24 18:13:17','3e982a17-8f7d-42b8-a993-7509e172dec8'),(16243,16243,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:18','2024-05-24 18:13:18','f6da6c60-8f2e-4f97-bf23-d50e6fa65b9e'),(16244,16244,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:18','2024-05-24 18:13:18','c0bf760f-5292-4143-998c-b23559fb72cd'),(16245,16245,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:19','2024-05-24 18:13:19','e6161d40-9413-44d2-8178-961a3596c3b0'),(16246,16246,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:19','2024-05-24 18:13:19','6444cb77-fc23-4b0d-96ca-5d00dc1921a5'),(16247,16247,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:19','2024-05-24 18:13:19','c5def0e9-d835-4304-b236-5da0c62f2da3'),(16248,16248,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:19','2024-05-24 18:13:19','04027ccf-93d2-4095-8710-5071171892e6'),(16249,16249,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:20','2024-05-24 18:13:20','e06ae3cb-da09-4ba3-bc64-5bfd4060dcc2'),(16250,16250,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:20','2024-05-24 18:13:20','9a2d6126-14a7-4838-a4df-6ba6c6e7a9ff'),(16251,16251,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:21','2024-05-24 18:13:21','a7f205c4-54c3-404f-b82d-8c64694e45f1'),(16252,16252,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:21','2024-05-24 18:13:21','5c2477aa-91e6-4942-abe3-123a3a8c6e98'),(16253,16253,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:22','2024-05-24 18:13:22','a02adba2-4679-4580-a6b7-5d6defbdb50e'),(16254,16254,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:22','2024-05-24 18:13:22','44c85f36-eb6e-4ca3-a6ad-617ece595e14'),(16255,16255,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:22','2024-05-24 18:13:22','376868d7-b178-40b7-ab97-25adb743a9fd'),(16256,16256,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:22','2024-05-24 18:13:22','6d82111b-2a18-4136-97a0-2b7ba3b78450'),(16257,16257,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:23','2024-05-24 18:13:23','089e3326-d10a-40cd-a344-6268eaff78f1'),(16258,16258,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:23','2024-05-24 18:13:23','04468043-0bcc-4149-87e2-09bba69082a1'),(16259,16259,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:24','2024-05-24 18:13:24','2d48ee02-4e4f-47f2-a7ad-a113309a3d34'),(16260,16260,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:24','2024-05-24 18:13:24','26b17bb7-eea5-4e79-96b9-a1644ca2d103'),(16261,16261,1,NULL,NULL,NULL,NULL,1,'2024-05-24 18:13:25','2024-05-24 18:13:25','6d4e84ae-d152-46b8-b311-d6c98d4a26cc'),(16262,16262,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Mpox is a disease that is caused by infection with the Mpox virus, which is in the genus orthopoxvirus. Mpox transmission can occur through direct contact with lesions or bodily fluids, indirect contact through fomites (materials that were in contact with lesions or bodily fluids), and exposure to large respiratory droplets through prolonged face-to-face contact. Infection prevention and control measures can help prevent or limit the spread of Mpox in healthcare settings.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Mpox\"}',1,'2024-05-24 18:13:25','2024-05-24 18:13:25','be03b94e-2140-4f6b-9269-16d15c2f4d84'),